{"id":2033,"date":"2026-01-10T09:15:44","date_gmt":"2026-01-10T00:15:44","guid":{"rendered":"https:\/\/info.zanet.biz\/?p=2033"},"modified":"2026-01-10T09:21:01","modified_gmt":"2026-01-10T00:21:01","slug":"notebooklm%e3%82%92%e5%88%a9%e7%94%a8%e3%81%97%e3%81%9f%e5%8c%bb%e5%ad%a6%e7%9f%a5%e8%ad%98%e3%81%ae%e3%82%a2%e3%83%83%e3%83%97%e3%83%87%e3%83%bc%e3%83%88","status":"publish","type":"post","link":"https:\/\/info.zanet.biz\/?p=2033","title":{"rendered":"NotebookLM\u3092\u5229\u7528\u3057\u305f\u533b\u5b66\u77e5\u8b58\u306e\u30a2\u30c3\u30d7\u30c7\u30fc\u30c8"},"content":{"rendered":"\n

NotebookLM\u306e\u4f7f\u7528\u6cd5\u6982\u8981<\/strong><\/p>\n\n\n\n

NotebookLM\uff08\u4ee5\u4e0bNLM\uff09\u306fArtificial Intelligence (AI)\u304c\u53c2\u7167\u3059\u308b\u60c5\u5831\u30bd\u30fc\u30b9\u3092\u5229\u7528\u8005\u304c\u8a2d\u5b9a\u3067\u304d\u308b\u306e\u304c\u7279\u5fb4\u3067\u3042\u308b\u3002\u30a6\u30a7\u30d6\u3067\u53c2\u7167\u3067\u304d\u308b\u60c5\u5831\u306b\u57fa\u3065\u3044\u3066\u56de\u7b54\u3092\u751f\u6210\u3059\u308b\u308f\u3051\u3067\u306f\u306a\u3044\u3002\u30bd\u30fc\u30b9\u3068\u3057\u3066\u8a2d\u5b9a\u3067\u304d\u308b\u60c5\u5831\u306f\u69d8\u3005\u3067\u3001\u30a6\u30a7\u30d6\u4e0a\u306e\u60c5\u5831\u306f\u7279\u5b9a\u306eURL\u3092\u30bd\u30fc\u30b9\u306b\u30a2\u30c3\u30d7\u30ed\u30fc\u30c9\u3059\u308b\u3053\u3068\u3067\u3001\u305d\u306e\u30da\u30fc\u30b8\u306e\u60c5\u5831\u3092\u30bd\u30fc\u30b9\u3068\u3057\u3066\u5229\u7528\u3067\u304d\u3001\u305d\u308c\u3060\u3051\u3067\u306a\u304f\u3001PDF\u30d5\u30a1\u30a4\u30eb\u3001\u30c6\u30ad\u30b9\u30c8\u30d5\u30a1\u30a4\u30eb\u3001YouTube\u52d5\u753b\u306a\u3069\u3055\u307e\u3056\u307e\u306a\u60c5\u5831\u30d5\u30a1\u30a4\u30eb\u3092\u30bd\u30fc\u30b9\u3068\u3057\u3066\u5229\u7528\u3059\u308b\u3053\u3068\u304c\u3067\u304d\u308b\u3002<\/p>\n\n\n\n

\u30a2\u30c3\u30d7\u30ed\u30fc\u30c9\u304c\u30b5\u30dd\u30fc\u30c8\u3055\u308c\u3066\u3044\u308b\u30d5\u30a1\u30a4\u30eb\u5f62\u5f0f\u306f\u3001PDF, .txt, Markdown, \u97f3\u58f0\uff08\u4f8b: mp3\uff09, .docx, .avif, .bmp, .gif, .ico, .jp2, .png, .webp, .tif, .tiff, .heic, .heif, .jpeg, .jpg, .jpe\u3067\u3042\u308b\u3002\u3055\u3089\u306b\u3001Google\u30c9\u30e9\u30a4\u30d6\u306e\u30d5\u30a1\u30a4\u30eb\u3084\u3001\u30b3\u30d4\u30fc\u3057\u305f\u30c6\u30ad\u30b9\u30c8\u3092\u8cbc\u308a\u4ed8\u3051\u3066\u5229\u7528\u3059\u308b\u3053\u3068\u3082\u3067\u304d\u308b\u3002

NLM\u306e\u30b5\u30a4\u30c8\uff08https:\/\/notebooklm.google.com\/<\/a> \uff09\u3092\u958b\u304d\u3001\u53f3\u4e0a\u306e\uff0b\u65b0\u898f\u4f5c\u6210\u30dc\u30bf\u30f3\u3092\u30af\u30ea\u30c3\u30af\u3059\u308b\u3068\u3001\u6700\u521d\u306b\u30bd\u30fc\u30b9\u3092\u30a2\u30c3\u30d7\u30ed\u30fc\u30c9\u3059\u308b\u30d1\u30cd\u30eb\u304c\u8868\u793a\u3055\u308c\u308b\u3002<\/p>\n\n\n\n

\"\"<\/figure>\n\n\n\n

\u8907\u6570\u306e\u30d5\u30a1\u30a4\u30eb\u3092\u307e\u3068\u3081\u3066\u30c9\u30e9\u30c3\u30b0\u30a2\u30f3\u30c9\u30c9\u30ed\u30c3\u30d7\u3057\u3066\u3001\u30a2\u30c3\u30d7\u30ed\u30fc\u30c9\u3059\u308b\u3053\u3068\u304c\u3067\u304d\u308b\u3002\u30a2\u30c3\u30d7\u30ed\u30fc\u30c9\u304c\u5b8c\u4e86\u3059\u308b\u3068\u305d\u308c\u3089\u306e\u6982\u8981\u304c\u8868\u793a\u3055\u308c\u308b\u3002\uff08\u6982\u8981\u306e\u8868\u793a\u306b\u306f\u6642\u9593\u304c\u304b\u304b\u308b\u5834\u5408\u3082\u3042\u308b\uff09\u3002\u65b0\u898f\u306b\u30ce\u30fc\u30c8\u3092\u4f5c\u6210\u3057\u305f\u5834\u5408\u3001\u30ce\u30fc\u30c8\u306e\u30bf\u30a4\u30c8\u30eb\u306f\u30bd\u30fc\u30b9\u60c5\u5831\u304b\u3089\u81ea\u52d5\u7684\u306b\u4f5c\u6210\u3055\u308c\u308b\u304c\u3001\u5fc5\u8981\u306b\u5fdc\u3058\u3066\u66f8\u304d\u63db\u3048\u308b\u3002<\/p>\n\n\n\n

\"\"<\/figure>\n\n\n\n

\u5de6\u306e\u30bd\u30fc\u30b9\u306e\u30d1\u30cd\u30eb\u306b\u3001\u30bd\u30fc\u30b9\u306e\u60c5\u5831\u304c\u8868\u793a\u3055\u308c\u308b\u3002\u30bd\u30fc\u30b9\u3092\u8ffd\u52a0\u3057\u305f\u3044\u5834\u5408\u306f\u3001\u5de6\u306e\u30bd\u30fc\u30b9\u306e\u30d1\u30cd\u30eb\u306e\u4e0a\u306b\u3042\u308b\uff0b\u30bd\u30fc\u30b9\u3092\u8ffd\u52a0\u306e\u30dc\u30bf\u30f3\u3092\u30af\u30ea\u30c3\u30af\u3057\u3066\u3001\u30bd\u30fc\u30b9\u30a2\u30c3\u30d7\u30ed\u30fc\u30c9\u306e\u30d1\u30cd\u30eb\u304c\u8868\u793a\u3055\u305b\u308b\u3053\u3068\u304c\u3067\u304d\u308b\u3002<\/p>\n\n\n\n

NLM\u306e\u753b\u9762\u306f\u3001\u30bd\u30fc\u30b9\u3001\u30c1\u30e3\u30c3\u30c8\u3001Studio\u306e3\u3064\u306e\u30d1\u30cd\u30eb\u304b\u3089\u306a\u308b\u3002Studio\u306e\u30d1\u30cd\u30eb\u306b\u306f\u3001\u97f3\u58f0\u89e3\u8aac\u3001\u52d5\u753b\u89e3\u8aac\u3001\u30de\u30a4\u30f3\u30c9\u30de\u30c3\u30d7\u3001\u30ec\u30dd\u30fc\u30c8\u3001\u30d5\u30e9\u30c3\u30b7\u30e5\u30ab\u30fc\u30c9\u3001\u30c6\u30b9\u30c8\u3001\u30a4\u30f3\u30d5\u30a9\u30b0\u30e9\u30d5\u30a3\u30c3\u30af\u3001\u30b9\u30e9\u30a4\u30c9\u8cc7\u6599\u3001Data Table\u306e\u4f5c\u6210\u306e\u305f\u3081\u306e\u30dc\u30bf\u30f3\u304c\u4e26\u3093\u3067\u3044\u308b\u3002\u305d\u306e\u4e0b\u306b\u3001\u4fdd\u5b58\u3057\u305f\u30e1\u30e2\u306e\u4e00\u89a7\u304c\u8868\u793a\u3055\u308c\u308b\u3002<\/p>\n\n\n\n

\u4e2d\u592e\u306e\u30c1\u30e3\u30c3\u30c8\u306e\u30d1\u30cd\u30eb\u306e\u4e0b\u306b\u3001\u30d7\u30ed\u30f3\u30d7\u30c8\u3092\u66f8\u304d\u8fbc\u3080\u30d5\u30a3\u30fc\u30eb\u30c9\u304c\u3042\u308a\u3001\u66f8\u304d\u8fbc\u3093\u3067\u304b\u3089Enter\u30ad\u30fc\u3092\u62bc\u3059\u304b\u3001\u2192\u30dc\u30bf\u30f3\u3092\u30af\u30ea\u30c3\u30af\u3059\u308b\u3068\u56de\u7b54\u304c\u751f\u6210\u3055\u308c\u3001\u305d\u308c\u3092\u30e1\u30e2\u3068\u3057\u3066\u4fdd\u5b58\u3059\u308b\u3053\u3068\u304c\u3067\u304d\u308b\u3002<\/p>\n\n\n\n

\u30c1\u30e3\u30c3\u30c8\u306e\u30d1\u30cd\u30eb\u306e\u4e0a\u306b\u306f\u3001\u70b9\u304c\u7e26\u306b3\u3064\u4e26\u3093\u3060\u30dc\u30bf\u30f3\u304c\u3042\u308b\u304c\u3001\u305d\u3053\u3092\u30af\u30ea\u30c3\u30af\u3057\u3066\u3001\u30c1\u30e3\u30c3\u30c8\u306e\u5c65\u6b74\u3092\u524a\u9664\u3092\u9078\u629e\u3059\u308b\u3068\u30c1\u30e3\u30c3\u30c8\u306e\u5c65\u6b74\u3092\u524a\u9664\u3067\u304d\u308b\u3002NLM\u306f\u9023\u7d9a\u3057\u3066\u3044\u304f\u3064\u304b\u306e\u30d7\u30ed\u30f3\u30d7\u30c8\u3092\u5b9f\u884c\u3057\u305f\u5834\u5408\u3001\u524d\u306e\u30d7\u30ed\u30f3\u30d7\u30c8\u5b9f\u884c\u306e\u60c5\u5831\u304c\u6b8b\u3063\u3066\u304a\u308a\u3001\u305d\u308c\u3092\u524d\u63d0\u3068\u3057\u3066\u30d7\u30ed\u30f3\u30d7\u30c8\u304c\u5b9f\u884c\u3055\u308c\u308b\u305f\u3081\u3001\u305d\u308c\u3089\u306e\u5c65\u6b74\u3092\u30af\u30ea\u30a2\u3057\u3066\u65b0\u898f\u306b\u30d7\u30ed\u30f3\u30d7\u30c8\u3092\u5b9f\u884c\u3059\u308b\u5fc5\u8981\u304c\u3042\u308b\u5834\u5408\u306f\u3001\u4e00\u5ea6\u30c1\u30e3\u30c3\u30c8\u306e\u5c65\u6b74\u3092\u524a\u9664\u3059\u308b\u5fc5\u8981\u304c\u3042\u308b\u3002<\/p>\n\n\n\n

\"\"<\/figure>\n\n\n\n

\u5de6\u306e\u30bd\u30fc\u30b9\u306e\u30d1\u30cd\u30eb\u306b\u306f\u3001\u30a2\u30c3\u30d7\u30ed\u30fc\u30c9\u3057\u305f\u30d5\u30a1\u30a4\u30eb\u540d\u3001URL\u306a\u3069\u306e\u4e00\u89a7\u304c\u8868\u793a\u3055\u308c\u3001\u30bd\u30fc\u30b9\u306e\u7a2e\u985e\u306b\u3088\u3063\u3066\u9055\u3046\u30a2\u30a4\u30b3\u30f3\u304c\u7528\u3044\u3089\u308c\u3066\u3044\u308b\u3002\u307e\u305f\u3001\u30d7\u30ed\u30f3\u30d7\u30c8\u3092\u5b9f\u884c\u3059\u308b\u969b\u306b\u306f\u3001\u30bd\u30fc\u30b9\u3068\u3057\u3066\u4f7f\u7528\u3057\u305f\u3044\u3082\u306e\u3060\u3051\u3092\u30c1\u30a7\u30c3\u30af\u3092\u5165\u308c\u308b\u3053\u3068\u3067\u3001\u76ee\u7684\u306b\u5408\u308f\u305b\u305f\u9078\u629e\u304c\u3067\u304d\u308b\u3002\u30bd\u30fc\u30b9\u306e\u4e00\u89a7\u306e\u4e00\u756a\u4e0a\u304c\u3001\u3059\u3079\u3066\u306e\u30bd\u30fc\u30b9\u3092\u9078\u629e\u306b\u306a\u3063\u3066\u304a\u308a\u3001\u3053\u306e\u30c1\u30a7\u30c3\u30af\u30dc\u30c3\u30af\u30b9\u3067\u3059\u3079\u3066\u3092\u9078\u629e\u3057\u305f\u308a\u3001\u306f\u305a\u3057\u305f\u308a\u304c\u3067\u304d\u308b\u3002<\/p>\n\n\n\n

\u307e\u305f\u3001\u30bd\u30fc\u30b9\u540d\u3092\u6307\u5b9a\u3057\u3066\u30012\u3064\u306ePDF\u30d5\u30a1\u30a4\u30eb\u306e\u5185\u5bb9\u3092\u6bd4\u8f03\u3055\u305b\u305f\u308a\u3059\u308b\u3053\u3068\u3082\u3067\u304d\u308b\u3002\u4f8b\u3048\u3070\u3001\u4f5c\u6210\u30de\u30cb\u30e5\u30a2\u30eb\u306ePDF\u30d5\u30a1\u30a4\u30eb\u3092\u30a2\u30c3\u30d7\u30ed\u30fc\u30c9\u3057\u3066\u304a\u304d\u3001\u305d\u308c\u306b\u5f93\u3063\u3066\u4f5c\u6210\u3057\u305f\u6587\u66f8\u3092\u30a2\u30c3\u30d7\u30ed\u30fc\u30c9\u3057\u3066\u3042\u308b\u5834\u5408\u3001\u305d\u306e\u5185\u5bb9\u304c\u30de\u30cb\u30e5\u30a2\u30eb\u306b\u5f93\u3063\u3066\u3044\u308b\u304b\u3092\u30c1\u30a7\u30c3\u30af\u3055\u305b\u308b\u3088\u3046\u306a\u4f5c\u696d\u3082\u53ef\u80fd\u3067\u3042\u308b\u3002<\/p>\n\n\n\n

\u307e\u305f\u3001\u30d7\u30ed\u30f3\u30d7\u30c8\u3067\u5f97\u3089\u308c\u305f\u56de\u7b54\u3092\u30e1\u30e2\u306b\u4fdd\u5b58\u3057\u305f\u3089\u3001Studio\u306e\u30d1\u30cd\u30eb\u306b\u8868\u793a\u3055\u308c\u3066\u3044\u308b\u30e1\u30e2\u306e\u30bf\u30a4\u30c8\u30eb\u304b\u3089\u3001\u305d\u308c\u3092\u958b\u304f\u3068\u4e0b\u306e\u65b9\u306b\u3001\u30dc\u30bf\u30f3\u304c\u3042\u308a\u3001\u30bd\u30fc\u30b9\u306b\u5909\u63db\u3059\u308b\u3053\u3068\u304c\u3067\u304d\u308b\u3002\u305d\u306e\u30bd\u30fc\u30b9\u3060\u3051\u3092\u9078\u629e\u3057\u3066\u3001\u30a4\u30f3\u30d5\u30a9\u30b0\u30e9\u30d5\u30a3\u30c3\u30af\u3092\u4f5c\u6210\u3057\u305f\u308a\u3001\u52d5\u753b\u89e3\u8aac\u3092\u4f5c\u6210\u3057\u305f\u308a\u3059\u308b\u3053\u3068\u3082\u3067\u304d\u308b\u3002<\/p>\n\n\n\n

\u533b\u5b66\u77e5\u8b58\u306e\u30a2\u30c3\u30d7\u30c7\u30fc\u30c8<\/strong><\/p>\n\n\n\n

\u7279\u5b9a\u306e\u30c6\u30fc\u30de\u306b\u3064\u3044\u3066\u533b\u5b66\u77e5\u8b58\u3092\u30a2\u30c3\u30d7\u30c7\u30fc\u30c8\u3057\u305f\u3044\u5834\u5408\u3001\u3055\u307e\u3056\u307e\u306a\u65b9\u6cd5\u304c\u8003\u3048\u3089\u308c\u308b\u304c\u3001PubMed\u304b\u3089\u8ad6\u6587\u306e\u30a2\u30d6\u30b9\u30c8\u30e9\u30af\u30c8\u306e\u60c5\u5831\u3092\u53ce\u96c6\u3057\u3001\u305d\u308c\u3089\u3092NLM\u306e\u30bd\u30fc\u30b9\u306b\u30a2\u30c3\u30d7\u30ed\u30fc\u30c9\u3057\u3066\u3001\u30d7\u30ed\u30f3\u30d7\u30c8\u3067\u5fc5\u8981\u306a\u60c5\u5831\u3092\u5f15\u304d\u51fa\u3059\u3053\u3068\u304c\u3067\u304d\u308b\u304b\u8a66\u3057\u3066\u307f\u308b\u3053\u3068\u306b\u3059\u308b\u3002\u5143\u306e\u60c5\u5831\u306f\u82f1\u8a9e\u3067\u3042\u3063\u3066\u3082\u3001\u30d7\u30ed\u30f3\u30d7\u30c8\u306f\u65e5\u672c\u8a9e\u3067\u66f8\u304f\u3053\u3068\u304c\u3067\u304d\u3001\u56de\u7b54\u3082\u65e5\u672c\u8a9e\u3067\u5f97\u3089\u308c\u308b\u70b9\u306f\u5229\u70b9\u306e\u4e00\u3064\u3067\u3042\u308b\u3002<\/p>\n\n\n\n

NLM\u306eAI\u6a5f\u80fd\u3092\u5229\u7528\u3059\u308b\u3053\u3068\u3067\u3001\u4f8b\u3048\u3070\u3001\u6570\u5343\u4ef6\u3068\u3044\u3046\u591a\u6570\u306e\u8ad6\u6587\u306e\u30a2\u30d6\u30b9\u30c8\u30e9\u30af\u30c8\u60c5\u5831\u306b\u57fa\u3065\u3044\u3066\u3001\u5fc5\u8981\u306a\u60c5\u5831\u3092\u5f15\u304d\u51fa\u3059\u3053\u3068\u304c\u53ef\u80fd\u306b\u306a\u308b\u3068\u8003\u3048\u3089\u308c\u3001\u6587\u732e\u306e\u9078\u5b9a\u3001\u8aad\u307f\u8fbc\u307f\u306e\u4f5c\u696d\u3092\u3059\u308b\u3053\u3068\u306a\u304f\u3001\u77e5\u308a\u305f\u3044\u60c5\u5831\u3092\u5f97\u308b\u3053\u3068\u304c\u3067\u304d\u308b\u304b\u3082\u3057\u308c\u306a\u3044\u3002\u307e\u305f\u3001PICO\u5f62\u5f0f\u306e\u30af\u30a8\u30b9\u30c1\u30e7\u30f3\u306b\u5bfe\u3059\u308b\u56de\u7b54\u3092\u5f97\u305f\u3044\u5834\u5408\u3001\u30b7\u30b9\u30c6\u30de\u30c1\u30c3\u30af\u30ec\u30d3\u30e5\u30fc\/\u30e1\u30bf\u30a2\u30ca\u30ea\u30b7\u30b9\u3001\u30e9\u30f3\u30c0\u30e0\u5316\u6bd4\u8f03\u8a66\u9a13\uff08randomized controlled trial, RCT\uff09\u306b\u9650\u5b9a\u3057\u3066\u6587\u732e\u691c\u7d22\u3092\u884c\u3063\u305f\u5834\u5408\u306e\u3001\u6587\u732e\u9078\u5b9a\u306e\u904e\u7a0b\u3092\u7701\u7565\u3067\u304d\u308b\u3053\u3068\u3082\u8003\u3048\u3089\u308c\u308b\u3002\u3055\u3089\u306b\u3001PICO\u5f62\u5f0f\u306b\u9650\u5b9a\u3055\u308c\u308b\u3053\u3068\u306a\u304f\u3055\u307e\u3056\u307e\u306a\u7591\u554f\u306b\u56de\u7b54\u3092\u5f97\u3089\u308c\u308b\u3053\u3068\u304c\u53ef\u80fd\u306b\u306a\u308b\u3068\u8003\u3048\u3089\u308c\u308b\u3002<\/p>\n\n\n\n

\u305f\u3060\u3057\u3001AI\u306e\u9650\u754c\u304c\u3069\u3053\u306b\u73fe\u308c\u308b\u304b\u4e88\u6e2c\u3067\u304d\u306a\u3044\u70b9\u3082\u3042\u308a\u3001\u7d50\u679c\u3092\u305d\u306e\u307e\u307e\u3059\u3079\u3066\u6b63\u3057\u3044\u3082\u306e\u3068\u3057\u3066\u53d7\u3051\u6b62\u3081\u306a\u3044\u6ce8\u610f\u304c\u5fc5\u8981\u3067\u3042\u308b\u3002<\/p>\n\n\n\n

\u533b\u5b66\u6587\u732e\u306e\u53ce\u96c6<\/strong><\/p>\n\n\n\n

PubMed\u3067\u306f\u3001\u307b\u3068\u3093\u3069\u306e\u6587\u732e\u306f\u30a2\u30d6\u30b9\u30c8\u30e9\u30af\u30c8\u307e\u3067\u306f\u5165\u624b\u3059\u308b\u3053\u3068\u304c\u3067\u304d\u308b\u3002\u8457\u8005\u3001\u30bf\u30a4\u30c8\u30eb\u3001\u30a2\u30d6\u30b9\u30c8\u30e9\u30af\u30c8\u306e\u60c5\u5831\u3092\u591a\u6570\u306e\u6587\u732e\u304b\u3089\u53ce\u96c6\u3057\u3066\u3001\u305d\u308c\u3089\u3092\u30bd\u30fc\u30b9\u3068\u3057\u3066\u3001NLM\u306b\u30a2\u30c3\u30d7\u30ed\u30fc\u30c9\u3059\u308b\u3002\u76ee\u7684\u3059\u306a\u308f\u3061\u77e5\u308a\u305f\u3044\u3053\u3068\u306b\u5bfe\u3057\u3066\u3001\u504f\u308a\u306a\u304f\u3001\u7db2\u7f85\u7684\u306b\u6587\u732e\u3092\u53ce\u96c6\u3059\u308b\u3053\u3068\u304c\u91cd\u8981\u306b\u306a\u308b\u3002<\/p>\n\n\n\n

\u64cd\u4f5c\u624b\u9806<\/p>\n\n\n\n

1\uff0e\u77e5\u308a\u305f\u3044\u3053\u3068\u3092\u660e\u78ba\u306b\u3059\u308b\u3002<\/p>\n\n\n\n

\u3044\u308f\u3086\u308bForground question\u3067PICO\u5f62\u5f0f\u306e\u30af\u30a8\u30b9\u30c1\u30e7\u30f3\u3001\u4f8b\u3048\u3070\u3001\u300c\u5927\u8178\u30dd\u30ea\u30da\u30af\u30c8\u30df\u30fc\u3092\u53d7\u3051\u305f\u60a3\u8005\u30671\u5e74\u5f8c\u306b\u5927\u8178\u93e1\u306b\u3088\u308b\u30d5\u30a9\u30ed\u30fc\u30a2\u30c3\u30d7\u691c\u67fb\u3092\u53d7\u3051\u308b\u30683\u5e74\u5f8c\u306b\u691c\u67fb\u3092\u53d7\u3051\u308b\u5834\u5408\u3068\u6bd4\u3079\u3066\u5927\u8178\u764c\u306e\u767a\u75c7\u304c\u6e1b\u5c11\u3059\u308b\u304b\uff1f\u300d<\/p>\n\n\n\n

\u3044\u308f\u3086\u308bBackground question\u300c\u5927\u8178\u30dd\u30ea\u30fc\u30d7\u6cbb\u7642\u5f8c\u306e\u30b5\u30fc\u30d9\u30a4\u30e9\u30f3\u30b9\u306f\u3069\u306e\u3088\u3046\u306b\u3059\u3079\u304d\u304b\uff1f\u300d\u306e\u69d8\u306a\u30015W1H\u30bf\u30a4\u30d7\u306e\u30af\u30a8\u30b9\u30c1\u30e7\u30f3\u3002*What, Who, When, Where, Why, How<\/p>\n\n\n\n

\u3044\u305a\u308c\u306e\u5834\u5408\u3082\u3001\u4ee5\u4e0b\u306e\u9805\u76ee\u306f\u660e\u78ba\u306b\u5b9a\u7fa9\u3059\u308b\u5fc5\u8981\u304c\u3042\u308b\u3067\u3042\u308d\u3046\u3002<\/p>\n\n\n\n

\u5bfe\u8c61\u8005\uff1a\u75be\u60a3\u3001\u75c5\u614b\u3001\u4ed6<\/p>\n\n\n\n

\u4ecb\u5165\u3001\u8a3a\u65ad\u6cd5\u3001\u691c\u67fb\u3001\u30ea\u30b9\u30af\u30d5\u30a1\u30af\u30bf\u30fc\u306a\u3069<\/p>\n\n\n\n

\u75be\u60a3\u306e\u30a2\u30a6\u30c8\u30ab\u30e0\u3001\u4ecb\u5165\u306e\u52b9\u679c\u3092\u5206\u6790\u3059\u308b\u305f\u3081\u306b\u6e2c\u5b9a\u3055\u308c\u308b\u30a2\u30a6\u30c8\u30ab\u30e0\uff08\u30a2\u30a6\u30c8\u30ab\u30e0\u306e\u5185\u5bb9\uff09\u3001\u8a3a\u65ad\u306e\u30a2\u30a6\u30c8\u30ab\u30e0\u3068\u3057\u3066\u306e\u75be\u60a3\u30fb\u75c5\u614b\u3001\u8a3a\u65ad\u7cbe\u5ea6\u306a\u3069<\/p>\n\n\n\n

\uff12\uff0e\u77e5\u308a\u305f\u3044\u3053\u3068\/\u30af\u30a8\u30b9\u30c1\u30e7\u30f3\u306b\u56de\u7b54\u3092\u4e0e\u3048\u308b\u3067\u3042\u308d\u3046\u7814\u7a76\uff1d\u6a19\u7684\u7814\u7a76\u306f\u3069\u306e\u3088\u3046\u306a\u3082\u306e\u304b\u3092\u719f\u616e\u3059\u308b\u3002<\/p>\n\n\n\n

\u7814\u7a76\u30c7\u30b6\u30a4\u30f3<\/p>\n\n\n\n

\u7279\u5b9a\u306e\u7814\u7a76\u30c7\u30b6\u30a4\u30f3\u306b\u9650\u5b9a\u3057\u305f\u65b9\u304c\u3044\u3044\u5834\u5408\u3001\u4f8b\u3048\u3070\u3001\u7279\u5b9a\u306e\u6cbb\u7642\u306b\u95a2\u3057\u3066\u77e5\u308a\u305f\u3044\u5834\u5408\u3067\u3042\u308c\u3070\u3001\u6587\u732e\u691c\u7d22\u306e\u6bb5\u968e\u3067\u3001\u8a3a\u7642\u30ac\u30a4\u30c9\u30e9\u30a4\u30f3\u3001\u30e1\u30bf\u30a2\u30ca\u30ea\u30b7\u30b9\/\u30b7\u30b9\u30c6\u30de\u30c6\u30a3\u30c3\u30af\u30ec\u30d3\u30e5\u30fc\u3001\u30e9\u30f3\u30c0\u30e0\u5316\u6bd4\u8f03\u8a66\u9a13\u306b\u9650\u5b9a\u3059\u308b\u65b9\u6cd5\u3092\u3068\u308b\u3053\u3068\u3082\u3067\u304d\u308b\u3002<\/p>\n\n\n\n

\uff13\uff0e\u6a19\u7684\u7814\u7a76\u306e\u30bf\u30a4\u30c8\u30eb\u3001\u30a2\u30d6\u30b9\u30c8\u30e9\u30af\u30c8\u3001\u7d71\u5236\u8a9e\u306b\u542b\u307e\u308c\u308b\u3068\u601d\u308f\u308c\u308b\u8a9e\u53e5\u3092\u660e\u78ba\u306b\u3059\u308b\u3002<\/p>\n\n\n\n

Text word (TW)<\/p>\n\n\n\n

\u540c\u7fa9\u8a9e Thesaurus<\/p>\n\n\n\n

MeSH (MH)\u3001Entry word \u2192 MeSH database\u306e\u53c2\u7167\u304c\u5fc5\u9808<\/p>\n\n\n\n

\uff14\uff0e\u6e96\u5099\u7684\u6587\u732e\u691c\u7d22\u3092\u5b9f\u65bd\u3057\u3001\u7528\u3044\u308b\u3079\u304d\u691c\u7d22\u8a9e\u53e5\u3084MeSH terms\u3092\u78ba\u8a8d\u3059\u308b\u3002<\/p>\n\n\n\n

meta-analysis[TA]\u3084randomized controlled trial[PT]\u3001\u5fc5\u8981\u306a\u5834\u5408\u5e74\u5ea6 (\u4f8b\uff1a2022:2025[dp]) \u3092AND\u3067\u7d44\u307f\u5408\u308f\u305b\u5c11\u6570\u306e\u6587\u732e\u3092\u5f15\u304d\u51fa\u3059\u3002<\/p>\n\n\n\n

\u6a19\u7684\u6587\u732e\u306b\u8fd1\u3044\u6587\u732e\u3092\u898b\u3064\u3051\u3001Abstract\u3092\u8868\u793a\u3055\u305b\u3001MeSH terms\u3092\u8868\u793a\u3055\u305b\u3066\u3001\u6a19\u7684\u6587\u732e\u306b\u5fc5\u9808\u306e\u7528\u8a9e\u3092MeSH database\u3067\u958b\u3044\u3066\u3001\u968e\u5c64\u69cb\u9020\u3092\u78ba\u8a8d\u3057\u3001\u95a2\u9023\u3057\u305f\u8a9e\u53e5\u3092\u8abf\u3079\u308b\u3002<\/p>\n\n\n\n

\u65e2\u77e5\u306e\u6587\u732e\u304c\u3042\u308b\u5834\u5408\u3001\u305d\u306e\u6587\u732e\u3092PubMed\u3067\u691c\u7d22\u3057\u3066\u3001\u30a2\u30d6\u30b9\u30c8\u30e9\u30af\u30c8\u3092\u8868\u793a\u3055\u305b\u3001MeSH terms\u3092\u78ba\u8a8d\u3059\u308b\u3002<\/p>\n\n\n\n

\uff15\uff0e\u76ee\u7684\u306b\u5fdc\u3058\u3066\u7814\u7a76\u30c7\u30b6\u30a4\u30f3\u3092\u9650\u5b9a\u3059\u308b\u691c\u7d22\u30d5\u30a3\u30eb\u30bf\u30fc\u3092\u6c7a\u3081\u308b\u3002<\/p>\n\n\n\n

NLM\u3092\u7528\u3044\u308b\u5834\u5408\u3001\u5927\u91cf\u306e\u60c5\u5831\u3092\u6271\u3048\u308b\u306e\u3067\u3001\u6587\u732e\u9078\u5b9a\u4f5c\u696d\u3092\u8003\u616e\u3057\u3066\u3001\u6587\u732e\u6570\u3092\u5c11\u306a\u304f\u3059\u308b\u3053\u3068\u3092\u8003\u3048\u308b\u5fc5\u8981\u306f\u306a\u3044\u3002\u76ee\u7684\u306b\u5fdc\u3058\u3066\u3001\u60c5\u5831\u30bd\u30fc\u30b9\u306b\u504f\u308a\u304c\u306a\u304f\u5341\u5206\u306a\u60c5\u5831\u304c\u5f97\u3089\u308c\u308b\u3088\u3046\u306b\u8003\u3048\u308b\u3002<\/p>\n\n\n\n

clinical trial[PT] OR meta-analysis[PT] OR practice guideline[PT] OR systematic[sb]<\/p>\n\n\n\n

clinical trial[PT]\u306b\u306frandomized cotnrolled trial[PT\u3068controlled clinical trial[PT]\u306f\u4e0b\u4f4d\u6982\u5ff5\u306b\u542b\u307e\u308c\u308b\u3002<\/p>\n\n\n\n

RCT\u306b\u9650\u5b9a\u3059\u308b\u5834\u5408\uff1arandomized cotrolled trial[PT]<\/p>\n\n\n\n

Cochrane RCT filter \u611f\u5ea6\u6700\u5927\u5316\uff1a(randomized controlled trial [pt] OR controlled clinical trial [pt] OR randomized [tiab] OR placebo [tiab] OR drug therapy [sh] OR randomly [tiab] OR trial [tiab] OR groups [tiab])<\/p>\n\n\n\n

Cochrane RCT filter \u611f\u5ea6\u30fb\u7279\u7570\u5ea6\u6700\u5927\u5316\uff1a(randomized controlled trial [pt] OR controlled clinical trial [pt] OR randomized [tiab] OR placebo [tiab] OR clinical trials as topic [MeSH:noexp] OR randomly [tiab] OR trial [ti] NOT(animals [mh] NOT humans [mh]))<\/p>\n\n\n\n

\u8a00\u8a9e\u3001\u4eba\u5bfe\u8c61\uff1a humans[mh] AND (english[la] OR japanese[la])<\/p>\n\n\n\n

\u30a2\u30d6\u30b9\u30c8\u30e9\u30af\u30c8\u6709\u308a\uff1a  hasabstract[tw] *\u30a2\u30d6\u30b9\u30c8\u30e9\u30af\u30c8\u6709\u308a\u306b\u9650\u5b9a\u3059\u308b\u3002<\/p>\n\n\n\n

\uff15\uff0e\u691c\u7d22\u5f0f\u3092\u69cb\u6210\u3057PubMed\u691c\u7d22\u3092\u5b9f\u65bd\u3059\u308b\u3002
\u691c\u7d22\u5f0f\u306e\u4f5c\u6210\u3001PubMed\u691c\u7d22\u306b\u306fpmSearch\uff08https:\/\/stat.zanet.biz\/sr\/pmsearch.htm<\/a>\uff09\u3092\u5229\u7528\u3059\u308b\u3068\u4fbf\u5229\u3067\u3042\u308b\u3002\u8ad6\u7406\u6f14\u7b97\u5b50 OR\u3001AND\u3001NOT\u3002\u305f\u3060\u3057\u3001NOT\u306f\u539f\u5247\u4f7f\u7528\u3057\u306a\u3044\u3002<\/p>\n\n\n\n

\"\"<\/figure>\n\n\n\n

\u4e0a\u304b\u30893\u6bb5\u76ee\u306e\u30d5\u30a3\u30fc\u30eb\u30c9\u306b\u691c\u7d22\u8a9e\u53e5\u3092\u66f8\u304d\u8fbc\u3080\u3068\u3001\u305d\u306e\u4e0b\u306e\u30d5\u30a3\u30fc\u30eb\u30c9\u306b\u691c\u7d22\u5f0f\u304c\u81ea\u52d5\u3067\u4f5c\u6210\u3055\u308c\u308b\u3002OR\u306f;\u3092\u7528\u3044\u308b\u3002\u6539\u884c\u306fAND\u3068\u3057\u3066\u6271\u3046\u3002<\/p>\n\n\n\n

\u6cbb\u7642\u7684\u4ecb\u5165\u304c\u30c6\u30fc\u30de\u306e\u5834\u5408\u3067\u3042\u308c\u3070\u3001\u5c11\u306a\u304f\u3068\u3082\u3001Cochrane\u306eRCT\u30d5\u30a3\u30eb\u30bf\u30fc\u306e\u3044\u305a\u308c\u304b\u3092\u7d44\u307f\u5408\u308f\u305b\u305f\u691c\u7d22\u5f0f\u3068PubMed\u306ePublication type\u306e\u3044\u304f\u3064\u304b\u3092\u7d44\u307f\u5408\u308f\u305b\u305f\u691c\u7d22\u5f0f\u306e2\u7a2e\u985e\u3092\u7528\u3044\u308b\u3088\u3046\u306b\u3059\u308b\u3002\u5de6\u306e\u30d1\u30cd\u30eb\u306b\u3042\u308b\u3001Publication type\u306b\u30c1\u30a7\u30c3\u30af\u3092\u5165\u308c\u3066\u3001\u3055\u3089\u306bFilter\u304b\u3089Cochrane\u306eRCT\u7528\u30d5\u30a3\u30eb\u30bf\u30fc\u306a\u3069\u3092\u9078\u629e\u3057\u3066\u7d44\u307f\u5408\u308f\u305b\u308b\u3053\u3068\u304c\u3067\u304d\u308b\u3002\u307e\u305f\u3001Population\u3001Intervention (PI)\u306e\u8a9e\u53e5\u3060\u3051\u3067\u691c\u7d22\u3057\u3001\u7d50\u679c\u304c\u6570\u5343\u4ef6\u7a0b\u5ea6\u3067\u3042\u308c\u3070\u3001Human\u306b\u9650\u5b9a\u3059\u308b\u3060\u3051\u3067\u3082\u5341\u5206\u3067\u3042\u308d\u3046\u3002<\/p>\n\n\n\n

\u69d8\u3005\u306a\u691c\u7d22\u5f0f\u3092\u8a66\u3059\u5834\u5408\u3001How many?\u3067\u4e00\u5ea6\u6587\u732e\u6570\u3092\u78ba\u8a8d\u3059\u308b\u3002<\/p>\n\n\n\n

Search in PubMed\u3092\u30af\u30ea\u30c3\u30af\u3059\u308b\u3068PubMed\u304c\u958b\u304b\u308c\u3066\u3001\u305d\u306e\u691c\u7d22\u5f0f\u3067\u691c\u7d22\u304c\u5b9f\u884c\u3055\u308c\u308b\u3002\u3055\u3089\u306b\u3001MeSH terms\u306e\u691c\u8a0e\u3092\u3059\u308b\u3053\u3068\u3082\u8003\u3048\u308b\u3002\u307e\u305f\u3001\u30b9\u30da\u30eb\u306e\u30df\u30b9\u306a\u3069\u304c\u898b\u3064\u304b\u308b\u5834\u5408\u3082\u3042\u308b\u3002<\/p>\n\n\n\n

\u691c\u7d22\u5f0f\u304c\u78ba\u5b9a\u3057\u305f\u3089\u3001\u4e0a\u306e\u56f3\u306e\u69d8\u306b\u3001With abstract\u306b\u30c1\u30a7\u30c3\u30af\u3092\u5165\u308c\u3066\u3001One Action Retrieval\u3092\u30af\u30ea\u30c3\u30af\u3059\u308b\u3068\u3001100\u4ef6\u305a\u3064Enter\u30ad\u30fc\u3092\u62bc\u3057\u306a\u304c\u3089\uff08\u3042\u308b\u3044\u306fOK\u30dc\u30bf\u30f3\u3092\u30af\u30ea\u30c3\u30af\u3057\u306a\u304c\u3089\uff09\u3001PubMed\u304b\u3089\u3001\u691c\u7d22\u5f0f\u306b\u9069\u5408\u3059\u308b\u6587\u732e\u304c\u30c0\u30a6\u30f3\u30ed\u30fc\u30c9\u3055\u308c\u308b\u3002<\/p>\n\n\n\n

\"\"<\/figure>\n\n\n\n

\u7d42\u4e86\u3059\u308b\u3068\u3001\u4e0b\u306e\u30d5\u30a3\u30fc\u30eb\u30c9\u306b\u7d50\u679c\u304c\u66f8\u304d\u8fbc\u307e\u308c\u3001\u30a2\u30d6\u30b9\u30c8\u30e9\u30af\u30c8\u3092\u542b\u3080\u6587\u732e\u4e00\u89a7\u8868\u304c\u5225\u306e\u30bf\u30d6\u3067\u8868\u793a\u3055\u308c\u308b\u3002<\/p>\n\n\n\n

\"\"<\/figure>\n\n\n\n

\u30a2\u30d6\u30b9\u30c8\u30e9\u30af\u30c8\u3092\u542b\u3080\u6587\u732e\u4e00\u89a7\u8868\u306e\u4e0a\u306b\u3042\u308b\u3001Save as Excel file\u306e\u30dc\u30bf\u30f3\u3092Shift\u30ad\u30fc\u3092\u62bc\u3057\u306a\u304c\u3089\u30af\u30ea\u30c3\u30af\u3059\u308b\u3068\u3001\u7d50\u679c\u3092\u30c6\u30ad\u30b9\u30c8\u30d5\u30a1\u30a4\u30eb\u3068\u3057\u3066\u4fdd\u5b58\u3067\u304d\u308b\u3002\u4fdd\u5b58\u3057\u305f\u30d5\u30a1\u30a4\u30eb\u3092\u5f8c\u3067\u3001400\u4ef6\u305a\u3064\u306e\u30c6\u30ad\u30b9\u30c8\u30d5\u30a1\u30a4\u30eb\u306b\u5206\u5272\u3057\u3066\u3001NLM\u306e\u30bd\u30fc\u30b9\u306b\u30a2\u30c3\u30d7\u30ed\u30fc\u30c9\u3059\u308b\u306e\u306b\u7528\u3044\u308b\u3002<\/p>\n\n\n\n

pmSearch\u306e\u30a6\u30a4\u30f3\u30c9\u30a6\u306b\u623b\u308a\u3001\u5f15\u304d\u51fa\u3055\u308c\u305f\u6587\u732e\u6570\u3092\u78ba\u8a8d\u3057\u306a\u304c\u3089\u3001OK\u30dc\u30bf\u30f3\u3092\u30af\u30ea\u30c3\u30af\u3059\u308b\u3002<\/p>\n\n\n\n

\"\"<\/figure>\n\n\n\n

\u4e00\u756a\u4e0b\u306e\u30d5\u30a3\u30fc\u30eb\u30c9\u306b\u691c\u7d22\u7d50\u679c\u306e\u6587\u732e\u4e00\u89a7\u304c\u542b\u307e\u308c\u3066\u3044\u308b\u306e\u3067\u3001\u305d\u306e\u5de6\u306eWith link\u30dc\u30bf\u30f3\u3092\u30af\u30ea\u30c3\u30af\u3059\u308b\u3068\u6587\u732e\u4e00\u89a7\u306e\u8868\u304c\u65b0\u3057\u3044\u30bf\u30d6\u306b\u8868\u793a\u3055\u308c\u308b\u3002\uff08Record\u30dc\u30bf\u30f3\u3092\u30af\u30ea\u30c3\u30af\u3057\u3066\u3082\u6587\u732e\u306e\u4e00\u89a7\u8868\u3092\u4f5c\u6210\u3067\u304d\u308b\u304c\u3001\u6587\u732e\u6570\u304c\u7d041000\u4ef6\u3092\u8d85\u3048\u308b\u3068\u51e6\u7406\u306b\u6642\u9593\u304c\u304b\u304b\u308b\u305f\u3081\u3001\u4eca\u56de\u306e\u76ee\u7684\u306b\u306f\u7528\u3044\u306a\u3044\u3002\uff09<\/p>\n\n\n\n

\"\"<\/figure>\n\n\n\n

\u691c\u7d22\u5f0f\u3068\u691c\u7d22\u65e5\u6642\u304c1\u884c\u76ee\u306b\u8a18\u9332\u3055\u308c\u3066\u3044\u308b\u306e\u3067\u3001\u5de6\u4e0a\u306b\u3042\u308bSave as HTML file\u3092\u30af\u30ea\u30c3\u30af\u3057\u3066\u30d5\u30a1\u30a4\u30eb\u540d\u3092\u4ed8\u3051\u3066\u4fdd\u5b58\u3057\u3066\u304a\u304f\u3002\u3042\u3068\u3067\u3001\u4fdd\u5b58\u30d5\u30a1\u30a4\u30eb\u3092\u30c0\u30d6\u30eb\u30af\u30ea\u30c3\u30af\u3059\u308b\u3068\u30d6\u30e9\u30a6\u30b6\u3067\u958b\u3044\u3066\u307f\u308b\u3053\u3068\u304c\u3067\u304d\u308b\u3002\u307e\u305f\u3001Link\u306ePubMed\u306e\u90e8\u5206\u3092\u30af\u30ea\u30c3\u30af\u3059\u308b\u3068\u305d\u306e\u6587\u732e\u306eAbstract\u3092PubMed\u3067\u958b\u3044\u3066\u307f\u308b\u3053\u3068\u304c\u3067\u304d\u308b\u3002<\/p>\n\n\n\n

\u307e\u305f\u3001pmSearch\u3067Search in PubMed\u3092\u30af\u30ea\u30c3\u30af\u3059\u308b\u3053\u3068\u3067PubMed\u3067\u691c\u7d22\u7d50\u679c\u3092\u8868\u793a\u3057\u3001\u30a2\u30d6\u30b9\u30c8\u30e9\u30af\u30c8\u3092\u542b\u3080\u5f62\u5f0f\u3067\u30c6\u30ad\u30b9\u30c8\u30d5\u30a1\u30a4\u30eb\u3068\u3057\u3066\u30c0\u30a6\u30f3\u30ed\u30fc\u30c9\u3059\u308b\u3053\u3068\u3082\u3067\u304d\u308b\u3002PubMed\u306e\u691c\u7d22\u7d50\u679c\u306e\u30a2\u30d6\u30b9\u30c8\u30e9\u30af\u30c8\u306e\u30c0\u30a6\u30f3\u30ed\u30fc\u30c9\u306f\u3001PubMed\u306e\u691c\u7d22\u7d50\u679c\u306e\u753b\u9762\u3067\u3001Sort by:\u3092Most recent\u306b\u3057\u3066\u3001Save\u30dc\u30bf\u30f3\u3092\u30af\u30ea\u30c3\u30af\u3057\u3001Selection:\u3092All results\u3001Format\u3092Abstract (text)\u306b\u3057\u3066Create file\u3092\u30af\u30ea\u30c3\u30af\u3059\u308b\u3002\u30d5\u30a1\u30a4\u30eb\u30b5\u30a4\u30ba\u306fpmSearch\u3067With abstract\u3067\u4fdd\u5b58\u3057\u305f\u5834\u5408\u3088\u308a\u3001\u5927\u304d\u304f\u306a\u308b\u304c\u3001\u540c\u3058\u3088\u3046\u306b\u5206\u5272\u3057\u3001NLM\u306b\u30bd\u30fc\u30b9\u3068\u3057\u3066\u3001\u30a2\u30c3\u30d7\u30ed\u30fc\u30c9\u3059\u308b\u3053\u3068\u304c\u3067\u304d\u308b\u3002\uff09<\/p>\n\n\n\n

\"\"<\/figure>\n\n\n\n

pmSearch\u3067With abstract\u3067\u3001\u30a2\u30d6\u30b9\u30c8\u30e9\u30af\u30c8\u60c5\u5831\u3092\u30c6\u30ad\u30b9\u30c8\u30d5\u30a1\u30a4\u30eb\u3068\u3057\u3066\u30c0\u30a6\u30f3\u30ed\u30fc\u30c9\u3057\u305f\u5834\u5408\u306f\u3001\u3072\u3068\u3064\u306e\u6587\u732e\u306e\u30d6\u30ed\u30c3\u30af\u304c\u3001\u9023\u7d9a\u756a\u53f7\u3001Reference ID\u3001Citation\u3001Title\u3001Abstract\u3067\u69cb\u6210\u3055\u308c\u3001\u6587\u732e\u306e\u5883\u754c\u306f3\u3064\u306e\u6539\u884c\u3092\u542b\u3080\u3002<\/p>\n\n\n\n

PubMed\u306eAbstract (text)\u5f62\u5f0f\u306e\u5834\u5408\u306f\u3001\u3072\u3068\u3064\u306e\u6587\u732e\u306e\u30d6\u30ed\u30c3\u30af\u304c\u3001\u3088\u308a\u591a\u304f\u306e\u60c5\u5831\u3092\u542b\u3093\u3067\u304a\u308a\u3001\u9023\u7d9a\u756a\u53f7\uff0b\u30b8\u30e3\u30fc\u30ca\u30eb\u60c5\u5831\u3001\u30bf\u30a4\u30c8\u30eb\u3001\u8457\u8005\u540d\u3001\u8457\u8005\u60c5\u5831\u3001\u30a2\u30d6\u30b9\u30c8\u30e9\u30af\u30c8\u3001DOI\u3001PMID\u3001COI\u60c5\u5831\u3067\u69cb\u6210\u3055\u308c\u3001\u6587\u732e\u306e\u5883\u754c\u306f3\u3064\u306e\u6539\u884c\u3092\u542b\u3080\u3002\u305d\u306e\u307e\u307e\u4f7f\u7528\u3067\u304d\u308bCitation\u306e\u5f62\u5f0f\u306e\u30c6\u30ad\u30b9\u30c8\u306f\u542b\u307e\u308c\u3066\u3044\u306a\u3044\u3002<\/p>\n\n\n\n

\u5f8c\u8ff0\u3059\u308b\u3053\u308c\u3089\u30c6\u30ad\u30b9\u30c8\u30d5\u30a1\u30a4\u30eb\u306e\u51e6\u7406\u306f\u3069\u3061\u3089\u306e\u5f62\u5f0f\u306e\u30d5\u30a1\u30a4\u30eb\u3067\u3082\u53ef\u80fd\u3067\u3042\u308b\u3002<\/p>\n\n\n\n

\uff16\uff0e\u8907\u6570\u306e\u691c\u7d22\u5f0f\u306e\u7d50\u679c\u3092\u30de\u30fc\u30b8\u3059\u308b\u3002<\/p>\n\n\n\n

\u4eca\u56de\u3001Cochrane \u611f\u5ea6\u6700\u5927\u5316RCT\u30d5\u30a3\u30eb\u30bf\u30fc\u3092\u7528\u3044\u305f\u691c\u7d22\u7d50\u679c\u3001colon-polyp-coch-5124.txt\u3068PubMed\u306ePublication type\u3092\u7528\u3044\u305f\u691c\u7d22\u7d50\u679c\u3001colon-polyp-1585.txt\u306e2\u3064\u3092\u91cd\u8907\u3092\u9664\u3044\u3066\u30de\u30fc\u30b8\u3057\u3001\u3072\u3068\u3064\u306e\u30c6\u30ad\u30b9\u30c8\u30d5\u30a1\u30a4\u30eb\u306b\u307e\u3068\u3081\u308b\u4f5c\u696d\u3092\u884c\u3046\u3002<\/p>\n\n\n\n

\u305d\u306e\u305f\u3081\u306b\u3001Merge Article Abstract Files without PMID Duplicates\u3068\u3044\u3046\u30a6\u30a7\u30d6\u30c4\u30fc\u30eb\u3092\u4f5c\u6210\u3057\u305f\u3002<\/p>\n\n\n\n

URL https:\/\/stat.zanet.biz\/sr\/merge-abstracts.htm<\/a><\/p>\n\n\n\n

\u30c9\u30e9\u30c3\u30b0\u30a2\u30f3\u30c9\u30c9\u30ed\u30c3\u30d7\u306e\u30a8\u30ea\u30a2\u304c2\u3064\u3042\u308b\u306e\u3067\u3001\u305d\u308c\u305e\u308c\u306b\u4e0a\u8a18\u306e\u30c6\u30ad\u30b9\u30c8\u30d5\u30a1\u30a4\u30eb\u3092\u30c9\u30e9\u30c3\u30b0\u30a2\u30f3\u30c9\u30c9\u30ed\u30c3\u30d7\u3059\u308b\u3002\u4e0b\u306e\u56f3\u306e\u3088\u3046\u306a\u72b6\u614b\u306b\u306a\u308b\u306e\u3067Merge and Download\u30dc\u30bf\u30f3\u3092\u30af\u30ea\u30c3\u30af\u3059\u308b\u3002<\/p>\n\n\n\n

\"\"<\/figure>\n\n\n\n

\u30de\u30fc\u30b8\u3055\u308c\u305f\u6587\u732e\u6570\u304c\u63d0\u793a\u3055\u308c\u3001\u53f3\u4e0a\u306b\u540d\u524d\u3092\u4ed8\u3051\u3066\u4fdd\u5b58\u306e\u30dc\u30bf\u30f3\u304c\u73fe\u308c\u308b\u306e\u3067\u3001\u30af\u30ea\u30c3\u30af\u3057\u3001\u30d5\u30a1\u30a4\u30eb\u540d\u3092\u4ed8\u3051\u3066\u4fdd\u5b58\u3059\u308b\u3002\u3053\u306e\u30d5\u30a1\u30a4\u30eb\u306b\u306f\u30012\u3064\u306e\u30c6\u30ad\u30b9\u30c8\u30d5\u30a1\u30a4\u30eb\u304b\u3089\u91cd\u8907\u3092\u9664\u3044\u305f\u6587\u732e\u304c\u542b\u307e\u308c\u3066\u3044\u308b\u3002<\/p>\n\n\n\n

\"\"<\/figure>\n\n\n\n

3\u3064\u4ee5\u4e0a\u306e\u30d5\u30a1\u30a4\u30eb\u3092\u30de\u30fc\u30b8\u3057\u305f\u3044\u5834\u5408\u306f\u3001\u4fdd\u5b58\u3057\u305f\u30de\u30fc\u30b8\u3057\u305f\u30d5\u30a1\u30a4\u30eb\u3092\u7528\u3044\u3066\u3001\u4e0a\u8a18\u306e\u4f5c\u696d\u3092\u7e70\u308a\u8fd4\u3059\u3002<\/p>\n\n\n\n

\uff17\uff0e\u6587\u732e\u6570400\u305a\u3064\u306e\u30d5\u30a1\u30a4\u30eb\u306b\u5206\u5272\u3059\u308b\u3002<\/p>\n\n\n\n

NLM\u3067\u30a2\u30c3\u30d7\u30ed\u30fc\u30c9\u3059\u308b\u30d5\u30a1\u30a4\u30eb\u306e\u5927\u304d\u3055\u306b\u306f\u5236\u9650\u304c\u3042\u308a\u3001\u3042\u308b\u7a0b\u5ea6\u4f59\u88d5\u3082\u6301\u305f\u305b\u3066\u3001400\u4ef6\u305a\u3064\u306b\u5206\u5272\u3059\u308b\u3053\u3068\u3068\u3059\u308b\u3002\u5206\u5272\u306b\u306f\u3001\u30a6\u30a7\u30d6\u30c4\u30fc\u30eb\u3067\u3042\u308bDivide PubMed Abstract (text)  File\u3092\u7528\u3044\u308b\uff08\u8457\u8005\u4f5c\u6210\uff09\u3002<\/p>\n\n\n\n

URL https:\/\/stat.zanet.biz\/sr\/div-pubmed-abstract.htm<\/a><\/p>\n\n\n\n

\u5143\u30d5\u30a1\u30a4\u30eb\u3092\u30c9\u30e9\u30c3\u30b0\u30a2\u30f3\u30c9\u30c9\u30ed\u30c3\u30d7\u3059\u308b\u3068\u3001400\u4ef6\u305a\u3064\u306e\u30d5\u30a1\u30a4\u30eb\u306b\u5206\u5272\u3055\u308c\u3001\u5168\u90e8\u306e\u30d5\u30a1\u30a4\u30eb\u3092\u542b\u3080ZIP\u30d5\u30a1\u30a4\u30eb\u3082\u4f5c\u6210\u3055\u308c\u308b\u306e\u3067\u3001\u3053\u306eZIP\u30d5\u30a1\u30a4\u30eb\u3092\u30af\u30ea\u30c3\u30af\u3057\u3066\u3001\u540d\u524d\u3092\u4ed8\u3051\u3066\u4fdd\u5b58\u3059\u308b\u3002<\/p>\n\n\n\n

\"\"<\/figure>\n\n\n\n

\u4ee5\u4e0a\u3067\u3001NLM\u306b\u30a2\u30c3\u30d7\u30ed\u30fc\u30c9\u3059\u308b\u30d5\u30a1\u30a4\u30eb\u306e\u6e96\u5099\u304c\u3067\u304d\u305f\u3002\u4ee5\u4e0a\u306e\u624b\u9806\u306e\u5185\u3001\u6642\u9593\u3092\u8981\u3059\u308b\u306e\u306f\u3001\u6587\u732e\u691c\u7d22\u3067\u3042\u308a\u3001\u30a2\u30d6\u30b9\u30c8\u30e9\u30af\u30c8\u3092\u30c0\u30a6\u30f3\u30ed\u30fc\u30c9\u3057\u305f\u5f8c\u306e\u64cd\u4f5c\u306f\u77ed\u6642\u9593\u3067\u7d42\u4e86\u3059\u308b\u3002\u6587\u732e\u691c\u7d22\u304c\u91cd\u8981\u306a\u30d7\u30ed\u30bb\u30b9\u3067\u3042\u308a\u3001\u7db2\u7f85\u6027\u3092\u91cd\u8996\u3057\u3001\u719f\u616e\u3092\u91cd\u306d\u3001\u30c8\u30e9\u30a4\u30a2\u30f3\u30c9\u30a8\u30e9\u30fc\u3067\u9032\u3081\u308b\u5fc5\u8981\u304c\u3042\u308b\u3002<\/p>\n\n\n\n

\u4eca\u56de\u306e\u4f8b\u306f\u3001\u300c\u5927\u8178\u30dd\u30ea\u30fc\u30d7\u306e\u30dd\u30ea\u30da\u30af\u30c8\u30df\u30fc\u5f8c\u306e\u30d5\u30a9\u30ed\u30fc\u30a2\u30c3\u30d7\u306f\u3069\u308c\u304f\u3089\u3044\u306e\u9593\u9694\u3067\u884c\u3046\u3079\u304d\u304b\uff1f\u300d\u304c\u30af\u30a8\u30b9\u30c1\u30e7\u30f3\u3067\u3042\u308b\u3002\u4ee5\u4e0b\u306e\uff12\u3064\u306e\u691c\u7d22\u5f0f\u3092\u7528\u3044\u305f\u3002\u691c\u7d22\u5f0f\uff11\u306fPubMed\u306ePublication type\u3092\u7528\u3044\u3001\u691c\u7d22\u5f0f\uff12\u306fCochrane\u306e\u611f\u5ea6\u6700\u5927\u5316RCT\u30d5\u30a3\u30eb\u30bf\u30fc\u3092\u7528\u3044\u305f\u3002\u305d\u308c\u305e\u308c\u30011585\u4ef6\u30015124\u4ef6\u306e\u6587\u732e\u304c\u5f15\u304d\u51fa\u3055\u308c\u305f\u3002<\/p>\n\n\n\n

\u691c\u7d22\u5f0f\uff11\uff1a(“colonic polyps”[mh] OR “colorectal neoplasms”[mh] OR “colonic polyps”[tw]) AND (colonoscopy[mh] OR colonoscopy[tw] ) AND (follow-up OR aftercare[mh] OR “follow-up studies”[mh] OR surveillance[tiab]) AND (meta-analysis[pt] OR clinical trial[pt] OR comparative study[pt] OR multicenter study[pt] OR guideline[pt] OR systematic[sb]) AND humans[mh] AND (english[la] OR japanese[la]) AND hasabstract[tw]<\/p>\n\n\n\n

\u691c\u7d22\u5f0f\uff12\uff1a(“colonic polyps”[mh] OR “colorectal neoplasms”[mh] OR “colonic polyps”[tw]) AND (colonoscopy[mh] OR colonoscopy[tw] ) AND (english[la] OR japanese[la]) AND hasabstract[tw] AND (randomized controlled trial [pt] OR controlled clinical trial [pt] OR randomized [tiab] OR placebo [tiab] OR drug therapy [sh] OR randomly [tiab] OR trial [tiab] OR groups [tiab])<\/p>\n\n\n\n

\u4e21\u8005\u3092\u30de\u30fc\u30b8\u3057\u305f\u7d50\u679c\u30015885\u4ef6\u306e\u6587\u732e\u304c\u5f97\u3089\u308c\u3001\u305d\u308c\u3092400\u4ef6\u305a\u3064\u306e15\u306e\u30c6\u30ad\u30b9\u30c8\u30d5\u30a1\u30a4\u30eb\u306b\u5206\u5272\u3057\u305f\u3002<\/p>\n\n\n\n

NLM\u306e\u5229\u7528<\/strong><\/p>\n\n\n\n

\u3053\u3053\u304b\u3089\u306f\u3001NLM\u306eAI\u306e\u5229\u7528\u30d7\u30ed\u30bb\u30b9\u306b\u5165\u308b\u3002<\/p>\n\n\n\n

AI\u306b\u4f55\u3092\u3055\u305b\u305f\u3044\u306e\u304b\uff1f\u3001\u4f55\u3092\u30a2\u30a6\u30c8\u30d7\u30c3\u30c8\u3068\u3057\u3066\u6b32\u3057\u3044\u306e\u304b\u3092\u5341\u5206\u8003\u3048\u3001\u305d\u308c\u3092\u5b9f\u73fe\u3059\u308b\u30d7\u30ed\u30f3\u30d7\u30c8\u3092\u4f5c\u6210\u3059\u308b\u5fc5\u8981\u304c\u3042\u308b\u3002<\/p>\n\n\n\n

\u4eca\u56de\u306f\u3001\u5927\u8178\u30dd\u30ea\u30fc\u30d7\u5207\u9664\u5f8c\u306e\u30b5\u30fc\u30d9\u30a4\u30e9\u30f3\u30b9\u306b\u3064\u3044\u3066\u3001\u30d5\u30a9\u30ed\u30fc\u30a2\u30c3\u30d7\u306e\u9593\u9694\u306b\u3064\u3044\u3066\u8abf\u3079\u3088\u3046\u3068\u3057\u3066\u3044\u308b\u306e\u3067\u3001\u4ee5\u4e0b\u306e\u30d7\u30ed\u30f3\u30d7\u30c8\u3092\u7528\u3044\u305f\u3002<\/p>\n\n\n\n

\u3042\u306a\u305f\u306f\u3001\u6d88\u5316\u5668\u75c5\u5c02\u9580\u533b\u3001\u6d88\u5316\u7ba1\u5185\u8996\u93e1\u5c02\u9580\u533b\u3067\u3059\u3002\u30bd\u30fc\u30b9\u306e\u60c5\u5831\u306b\u57fa\u3065\u3044\u3066\u3001\u5927\u8178\u93e1\u3067\u30dd\u30ea\u30da\u30af\u30c8\u30df\u30fc\u3092\u65bd\u884c\u5f8c\u30d5\u30a9\u30ed\u30fc\u30a2\u30c3\u30d7\u306e\u305f\u3081\u306e\u5927\u8178\u93e1\u306f\u3069\u308c\u304f\u3089\u3044\u306e\u9593\u9694\u3067\u65bd\u884c\u3059\u3079\u304d\u304b\u3001\u30b5\u30fc\u30d9\u30a4\u30e9\u30f3\u30b9\u306e\u65b9\u91dd\u306b\u3064\u3044\u3066\u307e\u3068\u3081\u3066\u304f\u3060\u3055\u3044\u3002\u30bd\u30fc\u30b9\u306f3\u500b\u306e\u6539\u884c\u30b3\u30fc\u30c9\u3067\u533a\u5207\u3089\u308c\u305f\u30d6\u30ed\u30c3\u30af\u304c\u3072\u3068\u3064\u306e\u6587\u732e\u3067\u3059\u3002\u305d\u308c\u305e\u308c\u306e\u30d6\u30ed\u30c3\u30af\u306e3\u884c\u76ee\u304c\u6587\u732e\u306e\u66f8\u8a8c\u60c5\u5831\u306a\u306e\u3067\u3001\u5f15\u7528\u3057\u305f\u5834\u5408\u3001\u305d\u306e\u66f8\u8a8c\u60c5\u5831\u306e\u4e00\u89a7\u3092\u901a\u3057\u756a\u53f7\u3092\u4ed8\u3051\u3066\u3001\u6700\u5f8c\u306b\u53c2\u8003\u6587\u732e\u3068\u3057\u3066\u4ed8\u3051\u3066\u304f\u3060\u3055\u3044\u3002\u53c2\u8003\u6587\u732e\u306e\u66f8\u8a8c\u60c5\u5831\u306e\u6700\u5f8c\u306fPMID: PMID\u306e\u756a\u53f7\u3068\u306a\u3063\u3066\u3044\u307e\u3059\u304c\u3001PMID\u306e\u756a\u53f7\u306e\u6587\u5b57\u5217\u306e\u5f8c\u306b\u30b9\u30da\u30fc\u30b9\u3092\u5165\u308c\u3001\u7d9a\u3051\u3066\"https:\/\/pubmed.ncbi.nlm.nih.gov\/\" + \"PMID\u306e\u756a\u53f7\"+\"\/\"\u3092\u66f8\u304d\u5165\u308c\u3066\u304f\u3060\u3055\u3044\u3002<\/code><\/pre>\n\n\n\n
\u8981\u70b9\u306f\u3001\u2460 \u30da\u30eb\u30bd\u30ca\u3001\u3059\u306a\u308f\u3061\u3001\u8ab0\u304c\u3001\u3042\u308b\u3044\u306f\u8ab0\u306e\u305f\u3081\u306b\u3092\u6307\u793a\u3059\u308b\u3053\u3068\u3001\u2461 \u77e5\u308a\u305f\u3044\u3053\u3068\u3092\u660e\u78ba\u306b\u8ff0\u3079\u308b\u3001\u2462 \u5f15\u7528\u6587\u732e\u306e\u66f8\u8a8c\u60c5\u5831\u306e\u30ea\u30b9\u30c8\u306e\u4f5c\u6210\u3092\u6307\u793a\u3057\u305f\u3053\u3068\u3001\u3067\u3042\u308b\u3002<\/p>\n\n\n\n
\u5f97\u3089\u308c\u305f\u56de\u7b54\u306f\u4ee5\u4e0b\u306e\u901a\u308a\u3067\u3042\u308b\u3002<\/p>\n\n\n\n
\u51fa\u529b\u3055\u308c\u305f\u56de\u7b54\u306b\u306f\u3001\u53c2\u7167\u3057\u305f\u30c6\u30ad\u30b9\u30c8\u306e\u7b87\u6240\u3092\u8868\u793a\u3059\u308b\u305f\u3081\u306e\u756a\u53f7\u304c\u632f\u3089\u308c\u305f\u7b87\u6240\u304c\u3042\u308a\u3001\u305d\u3053\u3078\u30de\u30a6\u30b9\u3092\u30db\u30d0\u30ea\u30f3\u30b0\u3059\u308b\u3068\u305d\u306e\u7b87\u6240\u304c\u30dd\u30c3\u30d7\u30a2\u30c3\u30d7\u30d1\u30cd\u30eb\u306b\u8868\u793a\u3055\u308c\u3001\u305d\u3053\u3092\u30af\u30ea\u30c3\u30af\u3059\u308b\u3068\u305d\u306e\u7b87\u6240\u304c\u5de6\u306e\u30d1\u30cd\u30eb\u306b\u8868\u793a\u3055\u308c\u308b\u3002\u4e0b\u306e\u56f3\u306f\u524d\u8005\u306e\u5834\u5408\u3092\u793a\u3057\u3066\u3044\u308b\u3002\u30af\u30ea\u30c3\u30af\u3057\u305f\u5834\u5408\u306f\u3001\u30bd\u30fc\u30b9\u306e\u8a72\u5f53\u7b87\u6240\u304c\u5de6\u306e\u30d1\u30cd\u30eb\u306b\u8868\u793a\u3055\u308c\u308b\u306e\u3067\u3001\u305d\u306e\u524d\u5f8c\u3082\u30b9\u30af\u30ed\u30fc\u30eb\u3057\u3066\u78ba\u8a8d\u3059\u308b\u3053\u3068\u304c\u3067\u304d\u308b\u3002\u307e\u305f\u3001\u3053\u306e\u756a\u53f7\u3068\u5dfb\u672b\u306b\u4ed8\u3051\u3089\u308c\u305f\u6587\u732e\u30ea\u30b9\u30c8\u306e\u756a\u53f7\u3042\u308b\u3044\u306f\u9806\u756a\u306f\u540c\u3058\u3067\u306f\u306a\u3044\u3002<\/p>\n\n\n\n
\"\"<\/figure>\n\n\n\n
\u56de\u7b54\u304c\u51fa\u529b\u3055\u308c\u308b\u3068\u3001\u4e0b\u306b\u30e1\u30e2\u306b\u4fdd\u5b58\u30dc\u30bf\u30f3\u3068\u30b3\u30d4\u30fc\u30dc\u30bf\u30f3\u304c\u8868\u793a\u3055\u308c\u308b\u3002\u30b3\u30d4\u30fc\u30dc\u30bf\u30f3\u3092\u30af\u30ea\u30c3\u30af\u3057\u3066\u304b\u3089\u3001\u65b0\u898fGoogle\u30c9\u30ad\u30e5\u30e1\u30f3\u30c8\u3092\u958b\u3044\u3066\u3001\u305d\u3053\u306b\u8cbc\u308a\u4ed8\u3051\u3066\u4fdd\u5b58\u3057\u3066\u304a\u304f\u3053\u3068\u304c\u3067\u304d\u308b\u3002\u4ee5\u4e0b\u306b\u793a\u3059\u306e\u306f\u3001Google\u30c9\u30ad\u30e5\u30e1\u30f3\u30c8\u306e\u5185\u5bb9\u3092\u30b3\u30d4\u30fc\u3057\u3066\u8cbc\u308a\u4ed8\u3051\u305f\u3082\u306e\u3067\u3042\u308b\u3002<\/p>\n\n\n\n
\"\"<\/figure>\n\n\n\n
\u307e\u305f\u3001\u30e1\u30e2\u306b\u4fdd\u5b58\u30dc\u30bf\u30f3\u3092\u30af\u30ea\u30c3\u30af\u3059\u308b\u3068\u3001\u53f3\u306eStudio\u30d1\u30cd\u30eb\u306b\u30bf\u30a4\u30c8\u30eb\u304c\u8868\u793a\u3055\u308c\u308b\u3088\u3046\u306b\u306a\u308b\u306e\u3067\u3001\u305d\u3053\u3092\u30af\u30ea\u30c3\u30af\u3057\u3066\u3001\u30e1\u30e2\u306e\u30bf\u30a4\u30c8\u30eb\u3092\u5fc5\u8981\u306b\u5fdc\u3058\u3066\u66f8\u304d\u63db\u3048\u3066\u304a\u304f\u3002\u4fdd\u5b58\u3057\u305f\u30e1\u30e2\u306b\u306f\u3001\u30b3\u30d4\u30fc\u30dc\u30bf\u30f3\u306a\u3069\u306f\u7121\u3044\u3002<\/p>\n\n\n\n
\u30c1\u30e3\u30c3\u30c8\u306e\u30d1\u30cd\u30eb\u306b\u793a\u3055\u308c\u305f\u30d7\u30ed\u30f3\u30d7\u30c8\u306b\u5bfe\u3059\u308b\u56de\u7b54\u306f\u3001\u30c1\u30e3\u30c3\u30c8\u306e\u30d1\u30cd\u30eb\u306e\u4e0a\u306b\u3042\u308b\u3001\u70b9\u304c\u7e26\u306b3\u3064\u4e26\u3093\u3060\u30dc\u30bf\u30f3\u3092\u30af\u30ea\u30c3\u30af\u3059\u308b\u3068\u30c1\u30e3\u30c3\u30c8\u306e\u5c65\u6b74\u3092\u524a\u9664\u306e\u64cd\u4f5c\u3092\u3059\u308b\u307e\u3067\u306f\u305d\u306e\u307e\u307e\u6b8b\u3063\u3066\u304a\u308a\u3001\u4ee5\u964d\u306e\u30d7\u30ed\u30f3\u30d7\u30c8\u5b9f\u884c\u6642\u306b\u53c2\u7167\u3055\u308c\u308b\u3002<\/p>\n\n\n\n
Google\u30c9\u30ad\u30e5\u30e1\u30f3\u30c8\u306b\u8cbc\u308a\u4ed8\u3051\u308b\u3068\u3001\u6587\u732e\u53c2\u7167\u306eURL\u90e8\u5206\u306e\u6700\u5f8c\u306b\u30ab\u30fc\u30bd\u30eb\u3092\u304a\u3044\u3066\u30b9\u30da\u30fc\u30b9\u3092\u8ffd\u52a0\u3059\u308b\u3068\u3001URL\u304c\u30a2\u30af\u30c6\u30a3\u30d6\u306b\u306a\u308a\u3001\u30af\u30ea\u30c3\u30af\u3059\u308b\u3053\u3068\u3067\u3001\u5c0f\u30d1\u30cd\u30eb\u304c\u63d0\u793a\u3055\u308c\u3001\u305d\u306e\u4e2d\u306e\u9752\u5b57\u306e\u90e8\u5206\u3092\u30af\u30ea\u30c3\u30af\u3059\u308b\u3068\u3001PubMed\u306e\u8a72\u5f53\u3059\u308b\u6587\u732e\u306e\u30a2\u30d6\u30b9\u30c8\u30e9\u30af\u30c8\u304c\u958b\u304b\u308c\u308b\u3002\u3053\u3046\u3059\u308b\u3053\u3068\u3067\u3001\u5185\u5bb9\u3092\u78ba\u8a8d\u3059\u308b\u3053\u3068\u304c\u3067\u304d\u308b\u3002<\/p>\n\n\n\n
\"\"<\/figure>\n\n\n\n
*\u3053\u306e\u969b\u306b\u3001URL\u3092\u30ea\u30f3\u30af\u306e\u30bf\u30a4\u30c8\u30eb\u306b\u7f6e\u304d\u63db\u3048\u307e\u3059\u304b\uff1f\u306eOK\u30dc\u30bf\u30f3\u3092\u30af\u30ea\u30c3\u30af\u3059\u308b\u3068\u3001URL\u90e8\u5206\u304c\u305d\u306e\u8ad6\u6587\u306e\u30bf\u30a4\u30c8\u30eb\u306b\u7f6e\u304d\u63db\u308f\u308a\u3001\u305d\u3053\u3092\u30af\u30ea\u30c3\u30af\u3059\u308b\u3068PubMed\u306e\u8a72\u5f53\u6587\u732e\u306e\u30a2\u30d6\u30b9\u30c8\u30e9\u30af\u30c8\u304c\u958b\u304b\u308c\u308b\u3088\u3046\u306b\u306a\u308b\u3002\u4eca\u56de\u306f\u305d\u306e\u5fc5\u8981\u306f\u306a\u3044\u306e\u3067\u3001\u305d\u306e\u307e\u307e\u306b\u3057\u3066\u304a\u304f\u3002<\/p>\n\n\n\n
\u4ee5\u4e0b\u306b\u56de\u7b54\u306e\u5168\u6587\u3092\u793a\u3059\u3002<\/p>\n\n\n\n
\u5927\u8178\u30dd\u30ea\u30da\u30af\u30c8\u30df\u30fc\u5f8c\u306e\u30b5\u30fc\u30d9\u30a4\u30e9\u30f3\u30b9<\/summary>
\n
\u6d88\u5316\u5668\u75c5\u5c02\u9580\u533b\u304a\u3088\u3073\u6d88\u5316\u7ba1\u5185\u8996\u93e1\u5c02\u9580\u533b\u306e\u7acb\u5834\u304b\u3089\u3001\u63d0\u4f9b\u3055\u308c\u305f\u6587\u732e\u306b\u57fa\u3065\u304d\u3001\u5927\u8178\u5185\u8996\u93e1\u306b\u3088\u308b\u30dd\u30ea\u30da\u30af\u30c8\u30df\u30fc\u5f8c\u306e\u30b5\u30fc\u30d9\u30a4\u30e9\u30f3\u30b9\uff08\u7d4c\u904e\u89b3\u5bdf\uff09\u65b9\u91dd\u306b\u3064\u3044\u3066\u307e\u3068\u3081\u307e\u3059\u3002<\/p>\n\n\n\n
\u30b5\u30fc\u30d9\u30a4\u30e9\u30f3\u30b9\u306e\u9593\u9694\u306f\u3001\u521d\u56de\u5185\u8996\u93e1\uff08\u30d9\u30fc\u30b9\u30e9\u30a4\u30f3\uff09\u3067\u898b\u3064\u304b\u3063\u305f\u30dd\u30ea\u30fc\u30d7\u306e\u6570\u3001\u5927\u304d\u3055\u3001\u7d44\u7e54\u578b\uff08\u817a\u816b\u304b\u92f8\u6b6f\u72b6\u75c5\u5909\u304b\uff09\u3001\u304a\u3088\u3073\u7570\u5f62\u6210\u306e\u7a0b\u5ea6\u306b\u57fa\u3065\u304f\u300c\u30ea\u30b9\u30af\u5c64\u5225\u5316\u300d\u306b\u3088\u3063\u3066\u6c7a\u5b9a\u3059\u308b\u3053\u3068\u304c\u56fd\u969b\u7684\u306a\u30b3\u30f3\u30bb\u30f3\u30b5\u30b9\u3068\u306a\u3063\u3066\u3044\u307e\u3059\u3002<\/p>\n\n\n\n
1. \u30ea\u30b9\u30af\u5c64\u5225\u5316\u306b\u57fa\u3065\u304f\u30b5\u30fc\u30d9\u30a4\u30e9\u30f3\u30b9\u9593\u9694<\/p>\n\n\n\n
#\u4f4e\u30ea\u30b9\u30af\u7fa4\uff08Low Risk\uff09<\/p>\n\n\n\n
\u4e00\u822c\u7684\u306b\u3001\u5c11\u6570\u306e\u5c0f\u3055\u306a\u817a\u816b\u306e\u307f\u304c\u898b\u3064\u304b\u3063\u305f\u5834\u5408\u304c\u8a72\u5f53\u3057\u307e\u3059\u3002<\/p>\n\n\n\n
   \u5b9a\u7fa9: 1\uff5e2\u500b\u306e\u7ba1\u72b6\u817a\u816b\u3067\u3001\u5927\u304d\u3055\u304c10mm\u672a\u6e80\u3001\u304b\u3064\u9ad8\u5ea6\u7570\u5f62\u6210\uff08high-grade dysplasia\uff09\u3092\u4f34\u308f\u306a\u3044\u3082\u306e\u3002<\/p>\n\n\n\n
   \u63a8\u5968\u9593\u9694: \u591a\u304f\u306e\u30ac\u30a4\u30c9\u30e9\u30a4\u30f3\u3067\u306f\u30015\u5e74\u304b\u308910\u5e74\u5f8c\u306e\u30b5\u30fc\u30d9\u30a4\u30e9\u30f3\u30b9\u3001\u3042\u308b\u3044\u306f\u30b5\u30fc\u30d9\u30a4\u30e9\u30f3\u30b9\u3092\u884c\u308f\u305a\u5404\u56fd\u306e\u30b9\u30af\u30ea\u30fc\u30cb\u30f3\u30b0\u30d7\u30ed\u30b0\u30e9\u30e0\uff08\u4fbf\u6f5c\u8840\u691c\u67fb\u306a\u3069\uff09\u3078\u306e\u5fa9\u5e30\u3092\u63a8\u5968\u3057\u3066\u3044\u307e\u3059\u3002<\/p>\n\n\n\n
   \u6839\u62e0: \u4f4e\u30ea\u30b9\u30af\u817a\u816b\u5207\u9664\u5f8c\u306e\u9032\u884c\u6027\u816b\u760d\uff08Advanced Neoplasia\uff09\u306e\u767a\u751f\u30ea\u30b9\u30af\u306f\u3001\u30dd\u30ea\u30fc\u30d7\u304c\u306a\u304b\u3063\u305f\u7fa4\u3068\u6bd4\u8f03\u3057\u3066\u540c\u7b49\u304b\u3001\u308f\u305a\u304b\u306b\u9ad8\u3044\u7a0b\u5ea6\u3067\u3042\u308a\u3001\u983b\u7e41\u306a\u691c\u67fb\u306f\u4e0d\u8981\u3068\u3055\u308c\u3066\u3044\u307e\u3059\u3002\u7c73\u56fd\uff08USMSTF\uff09\u306e\u30ac\u30a4\u30c9\u30e9\u30a4\u30f3\u3067\u306f5\uff5e10\u5e74\u5f8c\u3001\u6b27\u5dde\uff08ESGE\uff09\u3084\u82f1\u56fd\uff08BSG\uff09\u306e\u30ac\u30a4\u30c9\u30e9\u30a4\u30f3\u3067\u306f\u3001\u30b9\u30af\u30ea\u30fc\u30cb\u30f3\u30b0\u30d7\u30ed\u30b0\u30e9\u30e0\u3078\u306e\u53c2\u52a0\u307e\u305f\u306f10\u5e74\u5f8c\u306e\u5927\u8178\u93e1\u304c\u63a8\u5968\u3055\u308c\u3066\u3044\u307e\u3059\u3002<\/p>\n\n\n\n
   \u5fae\u5c0f\u30dd\u30ea\u30fc\u30d7\u306e\u6271\u3044: 5mm\u4ee5\u4e0b\u306e\u5fae\u5c0f\u817a\u816b\uff08diminutive adenoma\uff09\u30686-9mm\u306e\u5c0f\u817a\u816b\uff08small adenoma\uff09\u3067\u306f\u30016-9mm\u306e\u65b9\u304c\u7570\u6642\u6027\u9032\u884c\u75c5\u5909\u306e\u30ea\u30b9\u30af\u304c\u9ad8\u3044\u3068\u3044\u3046\u30c7\u30fc\u30bf\u304c\u3042\u308a\u3001\u5fae\u5c0f\u817a\u816b\u306e\u307f\u306e\u5834\u5408\u306f\u9593\u9694\u3092\u5ef6\u3070\u3059\u3053\u3068\u304c\u691c\u8a0e\u3055\u308c\u3066\u3044\u307e\u3059\u3002<\/p>\n\n\n\n
#\u9ad8\u30ea\u30b9\u30af\u7fa4\uff08High Risk \/ Intermediate Risk\uff09<\/p>\n\n\n\n
\u9032\u884c\u3057\u305f\u817a\u816b\u3084\u591a\u6570\u306e\u817a\u816b\u304c\u898b\u3064\u304b\u3063\u305f\u5834\u5408\u304c\u8a72\u5f53\u3057\u307e\u3059\u3002<\/p>\n\n\n\n
   \u5b9a\u7fa9:<\/p>\n\n\n\n
       \u9032\u884c\u817a\u816b\uff08Advanced Adenoma\uff09\uff1a\u5927\u304d\u3055\u304c10mm\u4ee5\u4e0a\u3001\u7d68\u6bdb\u6210\u5206\u3092\u542b\u3080\u3001\u307e\u305f\u306f\u9ad8\u5ea6\u7570\u5f62\u6210\u3092\u4f34\u3046\u3082\u306e\u3002<\/p>\n\n\n\n
       \u591a\u767a\u817a\u816b\uff1a\u30ac\u30a4\u30c9\u30e9\u30a4\u30f3\u306b\u3088\u308a\u5b9a\u7fa9\u304c\u7570\u306a\u308a\u307e\u3059\u304c\u3001\u901a\u5e383\u500b\u4ee5\u4e0a\u3001\u3042\u308b\u3044\u306f5\u500b\u4ee5\u4e0a\u306e\u817a\u816b\u304c\u3042\u308b\u5834\u5408\u3002<\/p>\n\n\n\n
   \u63a8\u5968\u9593\u9694: \u4e00\u822c\u7684\u306b3\u5e74\u5f8c\u306e\u30b5\u30fc\u30d9\u30a4\u30e9\u30f3\u30b9\u304c\u63a8\u5968\u3055\u308c\u307e\u3059\u3002<\/p>\n\n\n\n
   \u6839\u62e0: \u9ad8\u30ea\u30b9\u30af\u817a\u816b\uff08\u9032\u884c\u817a\u816b\u3084\u591a\u767a\u817a\u816b\uff09\u3092\u6709\u3059\u308b\u60a3\u8005\u306f\u3001\u5c06\u6765\u7684\u306b\u9032\u884c\u6027\u816b\u760d\u3084\u5927\u8178\u764c\u304c\u767a\u751f\u3059\u308b\u30ea\u30b9\u30af\u304c\u6709\u610f\u306b\u9ad8\u3044\u305f\u3081\u3001\u3088\u308a\u77ed\u3044\u9593\u9694\u3067\u306e\u30b5\u30fc\u30d9\u30a4\u30e9\u30f3\u30b9\u304c\u5fc5\u8981\u3067\u3059\u3002<\/p>\n\n\n\n
   \u8d85\u9ad8\u30ea\u30b9\u30af: 10\u500b\u4ee5\u4e0a\u306e\u817a\u816b\u304c\u3042\u308b\u5834\u5408\u306f\u3001\u907a\u4f1d\u6027\u75be\u60a3\uff08\u5bb6\u65cf\u6027\u5927\u8178\u817a\u816b\u75c7\u306a\u3069\uff09\u306e\u53ef\u80fd\u6027\u3092\u8003\u616e\u3057\u3001\u907a\u4f1d\u30ab\u30a6\u30f3\u30bb\u30ea\u30f3\u30b0\u3078\u306e\u7d39\u4ecb\u3084\u3001\u3088\u308a\u983b\u7e41\u306a\u30b5\u30fc\u30d9\u30a4\u30e9\u30f3\u30b9\uff08\u4f8b\uff1a1\u5e74\u672a\u6e80\uff09\u304c\u63a8\u5968\u3055\u308c\u308b\u3053\u3068\u304c\u3042\u308a\u307e\u3059\u3002<\/p>\n\n\n\n
2. \u92f8\u6b6f\u72b6\u75c5\u5909\uff08Serrated Polyps\uff09\u306e\u30b5\u30fc\u30d9\u30a4\u30e9\u30f3\u30b9<\/p>\n\n\n\n
\u8fd1\u5e74\u3001\u92f8\u6b6f\u72b6\u75c5\u5909\u7d4c\u8def\uff08serrated pathway\uff09\u306b\u3088\u308b\u767a\u764c\u30ea\u30b9\u30af\u304c\u6ce8\u76ee\u3055\u308c\u3066\u304a\u308a\u3001\u3053\u308c\u3089\u306e\u75c5\u5909\u306b\u5bfe\u3059\u308b\u30b5\u30fc\u30d9\u30a4\u30e9\u30f3\u30b9\u3082\u898f\u5b9a\u3055\u308c\u3066\u3044\u307e\u3059\u3002<\/p>\n\n\n\n
   \u4f4e\u30ea\u30b9\u30af: 10mm\u672a\u6e80\u306e\u904e\u5f62\u6210\u6027\u30dd\u30ea\u30fc\u30d7\uff08\u7279\u306b\u76f4\u8178S\u72b6\u7d50\u8178\uff09\u3084\u3001\u7570\u5f62\u6210\u306e\u306a\u3044sessile serrated lesion (SSL) \u306f\u4f4e\u30ea\u30b9\u30af\u3068\u307f\u306a\u3055\u308c\u300110\u5e74\u5f8c\u306a\u3069\u306e\u9577\u671f\u30b5\u30fc\u30d9\u30a4\u30e9\u30f3\u30b9\u307e\u305f\u306f\u30b9\u30af\u30ea\u30fc\u30cb\u30f3\u30b0\u5fa9\u5e30\u304c\u63a8\u5968\u3055\u308c\u307e\u3059\u3002<\/p>\n\n\n\n
   \u9ad8\u30ea\u30b9\u30af: 10mm\u4ee5\u4e0a\u306e\u92f8\u6b6f\u72b6\u75c5\u5909\u3001\u307e\u305f\u306f\u7570\u5f62\u6210\u3092\u4f34\u3046\u92f8\u6b6f\u72b6\u75c5\u5909\uff08Traditional Serrated Adenoma\u3092\u542b\u3080\uff09\u306f\u9ad8\u30ea\u30b9\u30af\u3068\u307f\u306a\u3055\u308c\u30013\u5e74\u5f8c\u306e\u30b5\u30fc\u30d9\u30a4\u30e9\u30f3\u30b9\u304c\u63a8\u5968\u3055\u308c\u307e\u3059\u3002<\/p>\n\n\n\n
   \u307e\u305f\u3001\u92f8\u6b6f\u72b6\u75c5\u5909\u3068\u901a\u5e38\u306e\u817a\u816b\u304c\u4f75\u5b58\u3059\u308b\u5834\u5408\u3001\u9032\u884c\u816b\u760d\u306e\u30ea\u30b9\u30af\u304c\u5897\u52a0\u3059\u308b\u305f\u3081\u3001\u6ce8\u610f\u304c\u5fc5\u8981\u3067\u3059\u3002<\/p>\n\n\n\n
3. \u5206\u5272\u5207\u9664\uff08Piecemeal Resection\uff09\u5f8c\u306e\u30b5\u30fc\u30d9\u30a4\u30e9\u30f3\u30b9<\/p>\n\n\n\n
20mm\u3092\u8d85\u3048\u308b\u5927\u304d\u306a\u75c5\u5909\u3092\u5185\u8996\u93e1\u7684\u7c98\u819c\u5207\u9664\u8853\uff08EMR\uff09\u306a\u3069\u3067\u5206\u5272\u5207\u9664\u3057\u305f\u5834\u5408\u3001\u5c40\u6240\u518d\u767a\u306e\u30ea\u30b9\u30af\u304c\u9ad8\u304f\u306a\u308a\u307e\u3059\u3002<\/p>\n\n\n\n
   \u63a8\u5968\u65b9\u91dd: \u5207\u9664\u304b\u3089\u7d046\u30f6\u6708\u5f8c\u306b\u6700\u521d\u306e\u30b5\u30fc\u30d9\u30a4\u30e9\u30f3\u30b9\uff08SC1\uff09\u3092\u884c\u3044\u3001\u907a\u6b8b\u30fb\u518d\u767a\u304c\u306a\u3044\u304b\u78ba\u8a8d\u3059\u308b\u5fc5\u8981\u304c\u3042\u308a\u307e\u3059\u3002<\/p>\n\n\n\n
   \u9577\u671f\u7d4c\u904e: \u6700\u521d\u306e\u30b5\u30fc\u30d9\u30a4\u30e9\u30f3\u30b9\u3067\u518d\u767a\u304c\u306a\u3051\u308c\u3070\u3001\u305d\u306e\u5f8c\u306f1\u5e74\u5f8c\u30013\u5e74\u5f8c\u3068\u3044\u3063\u305f\u9593\u9694\u3067\u614e\u91cd\u306b\u7d4c\u904e\u89b3\u5bdf\u3092\u884c\u3044\u307e\u3059\u3002\u8853\u5f8c\u306e\u71b1\u51dd\u56fa\uff08\u30b9\u30cd\u30a2\u30c1\u30c3\u30d7\u30bd\u30d5\u30c8\u51dd\u56fa\u306a\u3069\uff09\u3084\u30af\u30ea\u30c3\u30d7\u9589\u9396\u304c\u518d\u767a\u7387\u4f4e\u4e0b\u306b\u5bc4\u4e0e\u3059\u308b\u53ef\u80fd\u6027\u304c\u3042\u308a\u307e\u3059\u3002<\/p>\n\n\n\n
4. \u5927\u8178\u764c\u5207\u9664\u5f8c\u306e\u30b5\u30fc\u30d9\u30a4\u30e9\u30f3\u30b9<\/p>\n\n\n\n
\u5927\u8178\u764c\u306e\u6839\u6cbb\u5207\u9664\u5f8c\u306e\u60a3\u8005\u3082\u3001\u7570\u6642\u6027\u75c5\u5909\u3084\u5c40\u6240\u518d\u767a\u306e\u30ea\u30b9\u30af\u304c\u3042\u308b\u305f\u3081\u30b5\u30fc\u30d9\u30a4\u30e9\u30f3\u30b9\u304c\u5fc5\u8981\u3067\u3059\u3002<\/p>\n\n\n\n
   \u63a8\u5968\u9593\u9694: \u8853\u5f8c1\u5e74\u5f8c\u306b\u5927\u8178\u5185\u8996\u93e1\u3092\u884c\u3044\u3001\u7570\u5e38\u304c\u306a\u3051\u308c\u3070\u6b21\u306f3\u5e74\u5f8c\u3001\u305d\u306e\u6b21\u306f5\u5e74\u5f8c\u3068\u9593\u9694\u3092\u7a7a\u3051\u3066\u3044\u304f\u306e\u304c\u4e00\u822c\u7684\u3067\u3059\u3002<\/p>\n\n\n\n
   \u8853\u524d\u691c\u67fb: \u8853\u524d\u306b\u9589\u585e\u306a\u3069\u3067\u5168\u5927\u8178\u306e\u89b3\u5bdf\u304c\u3067\u304d\u3066\u3044\u306a\u3044\u5834\u5408\u306f\u3001\u8853\u5f8c3\uff5e6\u30f6\u6708\u4ee5\u5185\u306b\u6b8b\u5b58\u7d50\u8178\u306e\u691c\u67fb\u3092\u884c\u3046\u3079\u304d\u3067\u3059\u3002<\/p>\n\n\n\n
5. \u305d\u306e\u4ed6\u306e\u91cd\u8981\u306a\u8003\u616e\u4e8b\u9805<\/p>\n\n\n\n
   \u8178\u7ba1\u524d\u51e6\u7f6e\uff08Bowel Preparation\uff09: \u524d\u51e6\u7f6e\u304c\u4e0d\u826f\uff08Poor\/Inadequate\uff09\u3067\u89b3\u5bdf\u4e0d\u5341\u5206\u306a\u5834\u5408\u306f\u3001\u30ac\u30a4\u30c9\u30e9\u30a4\u30f3\u901a\u308a\u306e\u9593\u9694\u3067\u306f\u306a\u304f\u30011\u5e74\u4ee5\u5185\u306a\u3069\u65e9\u671f\u306e\u518d\u691c\u67fb\u304c\u5fc5\u8981\u3067\u3059\u3002<\/p>\n\n\n\n
   \u5e74\u9f62\u3068\u5065\u5eb7\u72b6\u614b:<\/p>\n\n\n\n
       \u82e5\u5e74\u8005\uff0850\u6b73\u672a\u6e80\uff09: \u82e5\u5e74\u3067\u817a\u816b\u304c\u898b\u3064\u304b\u3063\u305f\u5834\u5408\u3067\u3082\u300150\u6b73\u4ee5\u4e0a\u3068\u540c\u69d8\u306e\u30ea\u30b9\u30af\u5c64\u5225\u5316\u306b\u57fa\u3065\u304f\u30b5\u30fc\u30d9\u30a4\u30e9\u30f3\u30b9\u9593\u9694\uff08\u4f4e\u30ea\u30b9\u30af\u306a\u30895\u5e74\u3001\u9ad8\u30ea\u30b9\u30af\u306a\u30893\u5e74\uff09\u304c\u59a5\u5f53\u3067\u3042\u308b\u3068\u3044\u3046\u5831\u544a\u304c\u3042\u308a\u307e\u3059\u3002<\/p>\n\n\n\n
       \u9ad8\u9f62\u8005\uff0875-80\u6b73\u4ee5\u4e0a\uff09: \u671f\u5f85\u4f59\u547d\u3084\u4f75\u5b58\u75be\u60a3\u3092\u8003\u616e\u3057\u3001\u30b5\u30fc\u30d9\u30a4\u30e9\u30f3\u30b9\u306e\u4e2d\u6b62\u3092\u500b\u5225\u306b\u691c\u8a0e\u3059\u3079\u304d\u3067\u3059\u3002<\/p>\n\n\n\n
   \u691c\u67fb\u306e\u8cea\uff08Quality of Colonoscopy\uff09: \u817a\u816b\u767a\u898b\u7387\uff08ADR\uff09\u304c\u9ad8\u3044\u5185\u8996\u93e1\u533b\u306b\u3088\u308b\u691c\u67fb\u3084\u3001\u9069\u5207\u306a\u629c\u53bb\u6642\u9593\uff086\u5206\u4ee5\u4e0a\uff09\u306e\u78ba\u4fdd\u306f\u3001\u4e2d\u9593\u671f\u764c\u306e\u30ea\u30b9\u30af\u3092\u4f4e\u6e1b\u3055\u305b\u308b\u305f\u3081\u3001\u30b5\u30fc\u30d9\u30a4\u30e9\u30f3\u30b9\u9593\u9694\u306e\u6c7a\u5b9a\u306b\u304a\u3044\u3066\u524d\u63d0\u3068\u306a\u308a\u307e\u3059\u3002<\/p>\n\n\n\n
\u307e\u3068\u3081<\/p>\n\n\n\n
\u30dd\u30ea\u30da\u30af\u30c8\u30df\u30fc\u5f8c\u306e\u30b5\u30fc\u30d9\u30a4\u30e9\u30f3\u30b9\u306f\u3001\u4e00\u5f8b\u3067\u306f\u306a\u304f\u300c\u30ea\u30b9\u30af\u306b\u5fdc\u3058\u305f\uff08Risk-stratified\uff09\u300d\u30a2\u30d7\u30ed\u30fc\u30c1\u304c\u5fc5\u9808\u3067\u3059\u3002<\/p>\n\n\n\n
1.  \u4f4e\u30ea\u30b9\u30af\uff081-2\u500b\u306e<10mm\u7ba1\u72b6\u817a\u816b\uff09: 5\uff5e10\u5e74\u5f8c\uff08\u307e\u305f\u306f\u30b9\u30af\u30ea\u30fc\u30cb\u30f3\u30b0\u5fa9\u5e30\uff09\u3002<\/p>\n\n\n\n
2.  \u9ad8\u30ea\u30b9\u30af\uff08\u22673\u500b\u3001\u226710mm\u3001\u9ad8\u5ea6\u7570\u5f62\u6210\/\u7d68\u6bdb\u6210\u5206\u3001\u307e\u305f\u306f\u9ad8\u30ea\u30b9\u30af\u92f8\u6b6f\u72b6\u75c5\u5909\uff09: 3\u5e74\u5f8c\u3002<\/p>\n\n\n\n
3.  \u4e0d\u5b8c\u5168\u5207\u9664\u30fb\u5206\u5272\u5207\u9664\u5f8c: 6\u30f6\u6708\u5f8c\u3002<\/p>\n\n\n\n
4.  \u5927\u8178\u764c\u8853\u5f8c: 1\u5e74\u5f8c\u3002<\/p>\n\n\n\n
\u3053\u308c\u3089\u306e\u65b9\u91dd\u306f\u3001\u7121\u99c4\u306a\u691c\u67fb\u3092\u6e1b\u3089\u3057\u3064\u3064\u3001\u5927\u8178\u764c\u306e\u4e88\u9632\u52b9\u679c\u3092\u6700\u5927\u5316\u3059\u308b\u3053\u3068\u3092\u76ee\u7684\u3068\u3057\u3066\u3044\u307e\u3059\u3002<\/p>\n\n\n\n
\u53c2\u8003\u6587\u732e<\/p>\n\n\n\n
1. Chen Y, Padilla Aponte J, Wang K, Du M, Lu Y, Polychronidis G, Song M: Comparative risk of high-risk neoplasia after polypectomy among individuals aged below 50 years versus 50 years and older. Gut 2025;75:72-80. doi: 10.1136\/gutjnl-2025-335275 PMID: 40850745 https:\/\/pubmed.ncbi.nlm.nih.gov\/40850745\/<\/a>\u00a0<\/p>\n\n\n\n
2.\u00a0 Uchiyama T, Takahashi H, Endo H, Kato S, Sakai E, Hosono K, Yoneda M, Inamori M, Hippo Y, Nakagama H, Nakajima A: Number of aberrant crypt foci in the rectum is a useful surrogate marker of colorectal adenoma recurrence. Dig Endosc 2012;24:353-7. doi: 10.1111\/j.1443-1661.2012.01289.x PMID: 22925289 https:\/\/pubmed.ncbi.nlm.nih.gov\/22925289\/<\/a>\u00a0<\/p>\n\n\n\n
3.\u00a0 Rex DK, Kahi CJ, Levin B, Smith RA, Bond JH, Brooks D, Burt RW, Byers T, Fletcher RH, Hyman N, Johnson D, Kirk L, Lieberman DA, Levin TR, O’Brien MJ, Simmang C, Thorson AG, Winawer SJ: Guidelines for colonoscopy surveillance after cancer resection: a consensus update by the American Cancer Society and US Multi-Society Task Force on Colorectal Cancer. CA Cancer J Clin 2006;56:160-7 quiz 185-6. doi: 10.3322\/canjclin.56.3.160 PMID: 16737948 https:\/\/pubmed.ncbi.nlm.nih.gov\/16737948\/<\/a>\u00a0<\/p>\n\n\n\n
4.\u00a0 Winawer SJ, Zauber AG, Fletcher RH, Stillman JS, O’brien MJ, Levin B, Smith RA, Lieberman DA, Burt RW, Levin TR, Bond JH, Brooks D, Byers T, Hyman N, Kirk L, Thorson A, Simmang C, Johnson D, Rex DK: Guidelines for colonoscopy surveillance after polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer and the American Cancer Society. CA Cancer J Clin 2006;56:143-59 quiz 184-5. doi: 10.3322\/canjclin.56.3.143 PMID: 16737947 https:\/\/pubmed.ncbi.nlm.nih.gov\/16737947\/<\/a>\u00a0<\/p>\n\n\n\n
5.\u00a0 Rex DK, Kahi CJ, Levin B, Smith RA, Bond JH, Brooks D, Burt RW, Byers T, Fletcher RH, Hyman N, Johnson D, Kirk L, Lieberman DA, Levin TR, O’Brien MJ, Simmang C, Thorson AG, Winawer SJ, American Cancer Society, US Multi-Society Task Force on Colorectal Cancer: Guidelines for colonoscopy surveillance after cancer resection: a consensus update by the American Cancer Society and the US Multi-Society Task Force on Colorectal Cancer. Gastroenterology 2006;130:1865-71. doi: 10.1053\/j.gastro.2006.03.013 PMID: 16697749 https:\/\/pubmed.ncbi.nlm.nih.gov\/16697749\/<\/a>\u00a0<\/p>\n\n\n\n
6.  Bobay MC, Lahr RE, Shultz J, Vemulapalli KC, Guardiola JJ, Rex DK: Safety of first surveillance colonoscopy at 12 months after piecemeal EMR of large nonpedunculated colorectal lesions. Gastrointest Endosc 2024;100:905-913. doi: 10.1016\/j.gie.2024.05.008 PMID: 38750975 https:\/\/pubmed.ncbi.nlm.nih.gov\/38750975\/<\/p>\n\n\n\n
7.  Sasson AN, Sheehan G, Yu A, Gupta A, Ling K, Kochar B, Ananthakrishnan AN: Yield and Predictors of Surveillance Colonoscopies in Older Adults With Long-standing Ulcerative Colitis. Clin Gastroenterol Hepatol 2022;20:e1353-e1364. doi: 10.1016\/j.cgh.2021.08.019 PMID: 34425278 https:\/\/pubmed.ncbi.nlm.nih.gov\/34425278\/<\/p>\n\n\n\n
8.  Waldmann E, Kammerlander A, Gessl I, Penz D, Majcher B, Hinterberger A, Trauner M, Ferlitsch M: New risk stratification after colorectal polypectomy reduces burden of surveillance without increasing mortality. United European Gastroenterol J 2021;9:947-954. doi: 10.1002\/ueg2.12119 PMID: 34343405 https:\/\/pubmed.ncbi.nlm.nih.gov\/34343405\/<\/p>\n\n\n\n
9.  Symonds E, Anwar S, Young G, Meng R, Coats M, Simpson K, Bampton P, Fraser R, Cock C: Sessile Serrated Polyps with Synchronous Conventional Adenomas Increase Risk of Future Advanced Neoplasia. Dig Dis Sci 2019;64:1680-1685. doi: 10.1007\/s10620-019-5454-8 PMID: 30627918 https:\/\/pubmed.ncbi.nlm.nih.gov\/30627918\/<\/p>\n\n\n\n
10. Jung YS, Kim NH, Park JH, Park DI, Sohn CI: Appropriate Surveillance Interval after Colonoscopic Polypectomy in Patients Younger than 50 Years. J Korean Med Sci 2019;34:e101. doi: 10.3346\/jkms.2019.34.e101 PMID: 30940997 https:\/\/pubmed.ncbi.nlm.nih.gov\/30940997\/<\/p>\n\n\n\n
11. Rutter MD, East J, Rees CJ, Cripps N, Docherty J, Dolwani S, Kaye PV, Monahan KJ, Novelli MR, Plumb A, Saunders BP, Thomas-Gibson S, Tolan DJM, Whyte S, Bonnington S, Scope A, Wong R, Hibbert B, Marsh J, Moores B, Cross A, Sharp L: British Society of Gastroenterology\/Association of Coloproctology of Great Britain and Ireland\/Public Health England post-polypectomy and post-colorectal cancer resection surveillance guidelines. Gut 2020;69:201-223. doi: 10.1136\/gutjnl-2019-319858 PMID: 31776230 https:\/\/pubmed.ncbi.nlm.nih.gov\/31776230\/<\/p>\n\n\n\n
12. Parker J, Gupta S, Torkington J, Dolwani S: Comparison of recommendations for surveillance of advanced colorectal polyps: A systematic review of guidelines. J Gastroenterol Hepatol 2023;38:854-864. doi: 10.1111\/jgh.16157 PMID: 36823764 https:\/\/pubmed.ncbi.nlm.nih.gov\/36823764\/<\/p>\n\n\n\n
13. Lee JK, Jensen CD, Levin TR, Doubeni CA, Zauber AG, Chubak J, Kamineni AS, Schottinger JE, Ghai NR, Udaltsova N, Zhao WK, Fireman BH, Quesenberry CP, Orav EJ, Skinner CS, Halm EA, Corley DA: Long-term Risk of Colorectal Cancer and Related Death After Adenoma Removal in a Large, Community-based Population. Gastroenterology 2020;158:884-894.e5. doi: 10.1053\/j.gastro.2019.09.039 PMID: 31589872 https:\/\/pubmed.ncbi.nlm.nih.gov\/31589872\/<\/p>\n\n\n\n
14. Butterly LF, Nadel MR, Anderson JC, Robinson CM, Weiss JE, Lieberman D, Shapiro JA: Impact of Colonoscopy Bowel Preparation Quality on Follow-up Interval Recommendations for Average-risk Patients With Normal Screening Colonoscopies: Data From the New Hampshire Colonoscopy Registry. J Clin Gastroenterol 2020;54:356-364. doi: 10.1097\/MCG.0000000000001115 PMID: 30106836 https:\/\/pubmed.ncbi.nlm.nih.gov\/30106836\/<\/p>\n\n\n\n
15. East JE, Atkin WS, Bateman AC, Clark SK, Dolwani S, Ket SN, Leedham SJ, Phull PS, Rutter MD, Shepherd NA, Tomlinson I, Rees CJ: British Society of Gastroenterology position statement on serrated polyps in the colon and rectum. Gut 2017;66:1181-1196. doi: 10.1136\/gutjnl-2017-314005 PMID: 28450390 https:\/\/pubmed.ncbi.nlm.nih.gov\/28450390\/<\/p>\n\n\n\n
16. Nakajima T, Sakamoto T, Hori S, Yamada S, Ikematsu H, Harada K, Chiu HM, Kiriyama S, Michida T, Hotta K, Sakamoto N, Abe T, Chino A, Fukuzawa M, Kobayashi N, Fukase K, Matsuda T, Murakami Y, Ishikawa H, Saito Y: Optimal surveillance interval after piecemeal endoscopic mucosal resection for large colorectal neoplasia: a multicenter randomized controlled trial. Surg Endosc 2022;36:515-525. doi: 10.1007\/s00464-021-08311-6 PMID: 33569725 https:\/\/pubmed.ncbi.nlm.nih.gov\/33569725\/<\/p>\n\n\n\n
17. Jung YS, Kim TJ, Nam E, Park CH: Comparative systematic review and meta-analysis of 1- to 5-mm versus 6- to 9-mm adenomas on the risk of metachronous advanced colorectal neoplasia. Gastrointest Endosc 2020;92:692-701.e2. doi: 10.1016\/j.gie.2020.04.042 PMID: 32334021 https:\/\/pubmed.ncbi.nlm.nih.gov\/32334021\/<\/p>\n\n\n\n
18. Cross AJ, Robbins EC, Pack K, Stenson I, Kirby PL, Patel B, Rutter MD, Veitch AM, Saunders BP, Duffy SW, Wooldrage K: Long-term colorectal cancer incidence after adenoma removal and the effects of surveillance on incidence: a multicentre, retrospective, cohort study. Gut 2020;69:1645-1658. doi: 10.1136\/gutjnl-2019-320036 PMID: 31953252 https:\/\/pubmed.ncbi.nlm.nih.gov\/31953252\/<\/p>\n\n\n\n
19. Wieszczy P, Kaminski MF, Franczyk R, Loberg M, Kobiela J, Rupinska M, Kocot B, Rupinski M, Holme O, Wojciechowska U, Didkowska J, Ransohoff D, Bretthauer M, Kalager M, Regula J: Colorectal Cancer Incidence and Mortality After Removal of Adenomas During Screening Colonoscopies. Gastroenterology 2020;158:875-883.e5. doi: 10.1053\/j.gastro.2019.09.011 PMID: 31563625 https:\/\/pubmed.ncbi.nlm.nih.gov\/31563625\/<\/p>\n\n\n\n
20. Tate DJ, Desomer L, Klein A, Brown G, Hourigan LF, Lee EY, Moss A, Ormonde D, Raftopoulos S, Singh R, Williams SJ, Zanati S, Byth K, Bourke MJ: Adenoma recurrence after piecemeal colonic EMR is predictable: the Sydney EMR recurrence tool. Gastrointest Endosc 2017;85:647-656.e6. doi: 10.1016\/j.gie.2016.11.027 PMID: 27908600 https:\/\/pubmed.ncbi.nlm.nih.gov\/27908600\/<\/p>\n\n\n\n
21. Kahi CJ, Boland CR, Dominitz JA, Giardiello FM, Johnson DA, Kaltenbach T, Lieberman D, Levin TR, Robertson DJ, Rex DK, United States Multi-Society Task Force on Colorectal Cancer: Colonoscopy Surveillance After Colorectal Cancer Resection: Recommendations of the US Multi-Society Task Force on Colorectal Cancer. Gastroenterology 2016;150:758-768.e11. doi: 10.1053\/j.gastro.2016.01.001 PMID: 26892199 https:\/\/pubmed.ncbi.nlm.nih.gov\/26892199\/<\/p>\n\n\n\n
22. Kahi CJ, Boland CR, Dominitz JA, Giardiello FM, Johnson DA, Kaltenbach T, Lieberman D, Levin TR, Robertson DJ, Rex DK: Colonoscopy Surveillance after Colorectal Cancer Resection: Recommendations of the US Multi-Society Task Force on Colorectal Cancer. Am J Gastroenterol 2016;111:337-46 quiz 347. doi: 10.1038\/ajg.2016.22 PMID: 26871541 https:\/\/pubmed.ncbi.nlm.nih.gov\/26871541\/<\/p>\n\n\n\n
23. Jover R, Bretthauer M, Dekker E, Holme \u00d8, Kaminski MF, L\u00f8berg M, Zauber AG, Hern\u00e1n MA, Lansdorp-Vogelaar I, Sunde A, McFadden E, Castells A, Regula J, Quintero E, Pellis\u00e9 M, Senore C, Kalager M, Dinis-Ribeiro M, Emilsson L, Ransohoff DF, Hoff G, Adami HO: Rationale and design of the European Polyp Surveillance (EPoS) trials. Endoscopy 2016;48:571-8. doi: 10.1055\/s-0042-104116 PMID: 27042931 https:\/\/pubmed.ncbi.nlm.nih.gov\/27042931\/<\/p>\n\n\n\n
24. Clark BT, Rustagi T, Laine L: What level of bowel prep quality requires early repeat colonoscopy: systematic review and meta-analysis of the impact of preparation quality on adenoma detection rate. Am J Gastroenterol 2014;109:1714-23 quiz 1724. doi: 10.1038\/ajg.2014.232 PMID: 25135006 https:\/\/pubmed.ncbi.nlm.nih.gov\/25135006\/<\/p>\n\n\n\n
25. Hassan C, Quintero E, Dumonceau JM, Regula J, Brand\u00e3o C, Chaussade S, Dekker E, Dinis-Ribeiro M, Ferlitsch M, Gimeno-Garc\u00eda A, Hazewinkel Y, Jover R, Kalager M, Loberg M, Pox C, Rembacken B, Lieberman D, European Society of Gastrointestinal Endoscopy: Post-polypectomy colonoscopy surveillance: European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy 2013;45:842-51. doi: 10.1055\/s-0033-1344548 PMID: 24030244 https:\/\/pubmed.ncbi.nlm.nih.gov\/24030244\/<\/p>\n\n\n\n
26. Leddin D, Enns R, Hilsden R, Fallone CA, Rabeneck L, Sadowski DC, Singh H, Canadian Association of Gastroenterology: Colorectal cancer surveillance after index colonoscopy: guidance from the Canadian Association of Gastroenterology. Can J Gastroenterol 2013;27:224-8. doi: 10.1155\/2013\/232769 PMID: 23616961 https:\/\/pubmed.ncbi.nlm.nih.gov\/23616961\/<\/p>\n\n\n\n
27. Winawer SJ, Zauber AG, O’Brien MJ, Ho MN, Gottlieb L, Sternberg SS, Waye JD, Bond J, Schapiro M, Stewart ET: Randomized comparison of surveillance intervals after colonoscopic removal of newly diagnosed adenomatous polyps. The National Polyp Study Workgroup. N Engl J Med 1993;328:901-6. doi: 10.1056\/NEJM199304013281301 PMID: 8446136 https:\/\/pubmed.ncbi.nlm.nih.gov\/8446136\/<\/p>\n\n\n\n
28. Winawer SJ, Zauber AG, Fletcher RH, Stillman JS, O’brien MJ, Levin B, Smith RA, Lieberman DA, Burt RW, Levin TR, Bond JH, Brooks D, Byers T, Hyman N, Kirk L, Thorson A, Simmang C, Johnson D, Rex DK: Guidelines for colonoscopy surveillance after polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer and the American Cancer Society. CA Cancer J Clin 2006;56:143-59 quiz 184-5. doi: 10.3322\/canjclin.56.3.143 PMID: 16737947 https:\/\/pubmed.ncbi.nlm.nih.gov\/16737947\/<\/p>\n\n\n\n
29. Cross AJ, Robbins EC, Pack K, Stenson I, Rutter MD, Veitch AM, Saunders BP, Duffy SW, Wooldrage K: Colorectal cancer risk following polypectomy in a multicentre, retrospective, cohort study: an evaluation of the 2020 UK post-polypectomy surveillance guidelines. Gut 2021;70:2307-2320. doi: 10.1136\/gutjnl-2020-323411 PMID: 33674342 https:\/\/pubmed.ncbi.nlm.nih.gov\/33674342\/<\/a>\u00a0<\/p>\n\n\n\n
30. Kim NH, Jung YS, Park JH, Park DI, Sohn CI: Risk of developing metachronous advanced colorectal neoplasia after colonoscopic polypectomy in patients aged 30 to 39 and 40 to 49 years. Gastrointest Endosc 2018;88:715-723. doi: 10.1016\/j.gie.2018.05.018 PMID: 29857003 https:\/\/pubmed.ncbi.nlm.nih.gov\/29857003\/<\/a>\u00a0<\/p>\n\n\n\n
31. Pinsky PF, Schoen RE: Contribution of Surveillance Colonoscopy to Colorectal Cancer Prevention. Clin Gastroenterol Hepatol 2020;18:2937-2944.e1. doi: 10.1016\/j.cgh.2020.01.037 PMID: 32017987 https:\/\/pubmed.ncbi.nlm.nih.gov\/32017987\/<\/p>\n\n\n\n
32. Gupta S, Earles A, Bustamante R, Patterson OV, Gawron AJ, Kaltenbach TR, Yassin H, Lamm M, Shah SC, Saini SD, Fisher DA, Martinez ME, Messer K, Demb J, Liu L: Adenoma Detection Rate and Clinical Characteristics Influence Advanced Neoplasia Risk After Colorectal Polypectomy. Clin Gastroenterol Hepatol 2023;21:1924-1936.e9. doi: 10.1016\/j.cgh.2022.10.003 PMID: 36270618 https:\/\/pubmed.ncbi.nlm.nih.gov\/36270618\/<\/a>\u00a0<\/p>\n\n\n\n
33. Tate DJ, Desomer L, Hourigan LF, Moss A, Singh R, Bourke MJ: Two-stage endoscopic mucosal resection is a safe and effective salvage therapy after a failed single-session approach. Endoscopy 2017;49:888-898. doi: 10.1055\/s-0043-110671 PMID: 28564715 https:\/\/pubmed.ncbi.nlm.nih.gov\/28564715\/<\/a>\u00a034. Klein A, Tate DJ, Jayasekeran V, Hourigan L, Singh R, Brown G, Bahin FF, Burgess N, Williams SJ, Lee E, Sidhu M, Byth K, Bourke MJ: Thermal Ablation of Mucosal Defect Margins Reduces Adenoma Recurrence After Colonic Endoscopic Mucosal Resection. Gastroenterology 2019;156:604-613.e3. doi: 10.1053\/j.gastro.2018.10.003 PMID: 30296436 https:\/\/pubmed.ncbi.nlm.nih.gov\/30296436\/<\/a><\/p>\n<\/div><\/details>\n\n\n\n
\u7d9a\u3044\u3066\u3001\u65e5\u672c\u3068\u6b27\u7c73\u306e\u65b9\u91dd\u306e\u9055\u3044\u306b\u3064\u3044\u3066\u3001\u4ee5\u4e0b\u306e\u30d7\u30ed\u30f3\u30d7\u30c8\u3067\u3001\u8abf\u3079\u308b\u3053\u3068\u306b\u3057\u305f\u3002<\/p>\n\n\n\n
\u5927\u8178\u30dd\u30ea\u30fc\u30d7\u6cbb\u7642\u5f8c\u306e\u30b5\u30fc\u30d9\u30a4\u30e9\u30f3\u30b9\u65b9\u91dd\u3067\u65e5\u672c\u3068\u6b27\u7c73\u306e\u9055\u3044\u306f\uff1f\n\u30bd\u30fc\u30b9\u306f3\u500b\u306e\u6539\u884c\u30b3\u30fc\u30c9\u3067\u533a\u5207\u3089\u308c\u305f\u30d6\u30ed\u30c3\u30af\u304c\u3072\u3068\u3064\u306e\u6587\u732e\u3067\u3059\u3002\u305d\u308c\u305e\u308c\u306e\u30d6\u30ed\u30c3\u30af\u306e3\u884c\u76ee\u304c\u6587\u732e\u306e\u66f8\u8a8c\u60c5\u5831\u306a\u306e\u3067\u3001\u5f15\u7528\u3057\u305f\u5834\u5408\u3001\u305d\u306e\u66f8\u8a8c\u60c5\u5831\u306e\u4e00\u89a7\u3092\u901a\u3057\u756a\u53f7\u3092\u4ed8\u3051\u3066\u3001\u6700\u5f8c\u306b\u53c2\u8003\u6587\u732e\u3068\u3057\u3066\u4ed8\u3051\u3066\u304f\u3060\u3055\u3044\u3002\u53c2\u8003\u6587\u732e\u306e\u66f8\u8a8c\u60c5\u5831\u306e\u6700\u5f8c\u306fPMID: PMID\u306e\u756a\u53f7\u3068\u306a\u3063\u3066\u3044\u307e\u3059\u304c\u3001PMID\u306e\u756a\u53f7\u306e\u6587\u5b57\u5217\u306e\u5f8c\u306b\u30b9\u30da\u30fc\u30b9\u3092\u5165\u308c\u3001\u7d9a\u3051\u3066\"https:\/\/pubmed.ncbi.nlm.nih.gov\/\" + \"PMID\u306e\u756a\u53f7\"+\"\/\"\u3092\u66f8\u304d\u5165\u308c\u3066\u304f\u3060\u3055\u3044\u3002<\/code><\/pre>\n\n\n\n
\u5f97\u3089\u308c\u305f\u56de\u7b54\u306f\u4ee5\u4e0b\u306e\u901a\u308a\u3067\u3042\u308b\u3002<\/p>\n\n\n\n
\u5927\u8178\u30dd\u30ea\u30da\u30af\u30c8\u30df\u30fc\u5f8c\u306e\u30b5\u30fc\u30d9\u30a4\u30e9\u30f3\u30b9\u65b9\u91dd\uff1a\u65e5\u672c\u3068\u6b27\u7c73\u306e\u9055\u3044<\/summary>
\n
\u5927\u8178\u30dd\u30ea\u30fc\u30d7\u6cbb\u7642\u5f8c\u306e\u30b5\u30fc\u30d9\u30a4\u30e9\u30f3\u30b9\u65b9\u91dd\u3067\u65e5\u672c\u3068\u6b27\u7c73\u306e\u9055\u3044\u306f\uff1f<\/p>\n\n\n\n
\u63d0\u4f9b\u3055\u308c\u305f\u6587\u732e\u60c5\u5831\u306b\u57fa\u3065\u304d\u3001\u5927\u8178\u30dd\u30ea\u30fc\u30d7\u6cbb\u7642\u5f8c\u306e\u30b5\u30fc\u30d9\u30a4\u30e9\u30f3\u30b9\u65b9\u91dd\u306b\u304a\u3051\u308b\u65e5\u672c\u3068\u6b27\u7c73\u306e\u9055\u3044\u306b\u3064\u3044\u3066\u307e\u3068\u3081\u307e\u3059\u3002<\/p>\n\n\n\n
1. \u30ac\u30a4\u30c9\u30e9\u30a4\u30f3\u7b56\u5b9a\u306e\u80cc\u666f\u3068\u57fa\u672c\u59ff\u52e2\u306e\u9055\u3044<\/strong><\/h3>\n\n\n\n
\u6b27\u7c73\u3068\u65e5\u672c\u3067\u306f\u3001\u30b5\u30fc\u30d9\u30a4\u30e9\u30f3\u30b9\u30ac\u30a4\u30c9\u30e9\u30a4\u30f3\u306e\u57fa\u76e4\u3068\u306a\u308b\u30a8\u30d3\u30c7\u30f3\u30b9\u3084\u57fa\u672c\u7406\u5ff5\u306b\u6b74\u53f2\u7684\u306a\u9055\u3044\u304c\u3042\u308a\u307e\u3059\u3002<\/p>\n\n\n\n